Text Size

A A A

Search


 

Home | Clinical Trials


Therapeutic Areas: Neurology | Hematology | Cardiology/Vascular Diseases | Family Medicine

Stroke Clinical Trials


A listing of Stroke medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Alabama

Athens : North Alabama Research Center LLC

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Athens : Office of Ernest L. Hendrix, MD, PC

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Athens : North Alabama Research Center, LLC

A Phase 3 clinical study for patients with Cardiovascular Disease

Athens :

A Phase 3 clinical study for patients with Cardiovascular Disease

Athens : Office of Ernest L. Hendrix, MD, PC

A Phase 3 clinical study for patients with Cardiovascular Disease

Birmingham : Cardiovascular Associates of the Southeast, LLC

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Birmingham : University of Alabama at Birmingham (Drug Shipment)

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Birmingham : The Kirklin Clinic

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Birmingham :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Birmingham : 1160.129.32261 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Birmingham : University of Alabama, Birmingham

A clinical trial to evaluate treatments using Flow Detection System for patients with Right to Left Shunt, Patent Foramen Ovale or Atrial Septal Defect

Birmingham :

A Phase 3 clinical study for patients with Cardiovascular Disease

Birmingham : The Kirklin Clinic

A Phase 3 clinical study for patients with Cardiovascular Disease

Birmingham : University of Alabama at Birmingham (Drug Shipment)

A Phase 3 clinical study for patients with Cardiovascular Disease

Birmingham :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Columbiana :

A Phase 3 clinical study for patients with Cardiovascular Disease

Gulf Shores :

A Phase 3 clinical study for patients with Cardiovascular Disease

Homewood :

A Phase 3 clinical study for patients with Cardiovascular Disease

Hoover :

A Phase 3 clinical study for patients with Cardiovascular Disease

Huntsville : Saadat Ansari Internal Medicine

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Huntsville :

A Phase 3 clinical study for patients with Cardiovascular Disease

Huntsville : The Office of Saadat Ansari MD LLC

A Phase 3 clinical study for patients with Cardiovascular Disease

Mobile :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Mobile : 1160.129.32394 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Mobile :

A Phase 3 clinical study for patients with Cardiovascular Disease

Mobile :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Ozark :

A Phase 3 clinical study for patients with Cardiovascular Disease

Scottsboro : 1160.129.32054 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Tuscaloosa : 1160.129.32174 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Tuscaloosa :

A Phase 3 clinical study for patients with Cardiovascular Disease

Alaska

Anchorage : 1160.129.32335 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Arizona

Chandler :

A Phase 3 clinical study for patients with Cardiovascular Disease

Gilbert : Acorda Investigational Site Updated

A clinical trial seeking patients for a research study for the treatment of Post-Ischemic Stroke

Gilbert : Mercy Gilbert and Chandler Medical Center

A Phase 1/Phase 2 clinical study for patients with Ischemic Stroke

Gilbert :

A Phase 3 clinical study for patients with Cardiovascular Disease

Glendale : Arrowhead Internal Medicine

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Glendale : 1160.129.32284 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Glendale : Arrowhead Internal Medicine

A Phase 3 clinical study for patients with Cardiovascular Disease

Glendale :

A Phase 3 clinical study for patients with Cardiovascular Disease

Goodyear :

A Phase 3 clinical study for patients with Cardiovascular Disease

Hot Springs : 1160.129.32156 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Lake Havasu City : 1160.129.32151 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Mesa :

A Phase 3 clinical study for patients with Cardiovascular Disease

Phoenix : Mayo Clinic

A clinical research study of NBS-guided rTMS and Sham rTMS for the treatment of Stroke

Phoenix : Heart and Vascular Center of Arizona

A clinical trial to evaluate treatments using Flow Detection System for patients with Right to Left Shunt, Patent Foramen Ovale or Atrial Septal Defect

Phoenix :

A Phase 3 clinical study for patients with Cardiovascular Disease

Phoenix : Carl T. Hayden Medical Research Foundation

Patients are needed to participate in a clinical research study for the treatment of Atherosclerotic Disease, Carotid

Sierra Vista :

A Phase 3 clinical study for patients with Cardiovascular Disease

Tempe : Clinical Research Advantage, Inc./Ridge Family Practice (Administrative Mailing Only)

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Tempe : Clinical Research Advantage, Inc. (Administrative Mailing Only)

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Tempe : Clinical Research Advantage, Inc. (Administrative Mailing Only)

A Phase 3 clinical study for patients with Cardiovascular Disease

Tempe :

A Phase 3 clinical study for patients with Cardiovascular Disease

Tucson : Southwest Heart Group

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Tucson :

A Phase 3 clinical study for patients with Cardiovascular Disease

Tucson : Southwest Heart Group

A Phase 3 clinical study for patients with Cardiovascular Disease

Arkansas

Fort Smith : 1160.129.32266 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Fort Smith :

A Phase 3 clinical study for patients with Cardiovascular Disease

Hot Springs : 1160.129.32140 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Little Rock : 1160.129.32356 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Little Rock : 1160.129.32014 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Little Rock : 1160.129.32346 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Little Rock : 1160.129.32009 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Little Rock :

A Phase 3 clinical study for patients with Cardiovascular Disease

California

Pomona : Harrison Clinical Management Updated

BOTOX® Treatment in Pediatric Lower Limb Spasticity

Pomona : Harrison Clinical Management Updated

BOTOX® Treatment in Pediatric Upper Limb Spasticity

San Diego : Rady Children's Hospital Updated

BOTOX® Treatment in Pediatric Lower Limb Spasticity

San Diego : Rady Children's Hospital Updated

BOTOX® Treatment in Pediatric Upper Limb Spasticity

Anaheim :

A Phase 3 clinical study for patients with Cardiovascular Disease

Anaheim :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Beverly Hills :

A Phase 3 clinical study for patients with Cardiovascular Disease

Beverly Hills : 1160.189.10250 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Buena Park :

A Phase 3 clinical study for patients with Cardiovascular Disease

Carlsbad :

A Phase 3 clinical study for patients with Cardiovascular Disease

Carmichael :

A Phase 3 clinical study for patients with Cardiovascular Disease

Citrus Heights :

A Phase 3 clinical study for patients with Cardiovascular Disease

Concord : John Muir Physician Network Clinical Research Center

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Costa Mesa :

A Phase 3 clinical study for patients with Cardiovascular Disease

Covina :

A Phase 3 clinical study for patients with Cardiovascular Disease

Downey : Rancho Los Amigos National Rehabilitation Center

A clinical research study of NBS-guided rTMS and Sham rTMS for the treatment of Stroke

Downey :

A Phase 3 clinical study for patients with Cardiovascular Disease

El Cajon : Triwest Research Associates, LLC

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

El Cajon : Triwest Research Associates, LLC

A Phase 3 clinical study for patients with Cardiovascular Disease

El Cajon :

A Phase 3 clinical study for patients with Cardiovascular Disease

El Cajon : 1160.189.11229 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Encinitas : Encompass Clinical Research North Coast

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Encinitas : 1160.129.32035 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Fair Oaks :

A Phase 3 clinical study for patients with Cardiovascular Disease

Fountain Valley : 1160.129.32126 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Fresno : 1160.129.32019 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Gold River :

A Phase 3 clinical study for patients with Cardiovascular Disease

Greenbrae :

A Phase 3 clinical study for patients with Cardiovascular Disease

Huntington Park :

A Phase 3 clinical study for patients with Cardiovascular Disease

Irvine :

A Phase 3 clinical study for patients with Cardiovascular Disease

La Jolla :

A Phase 3 clinical study for patients with Cardiovascular Disease

La Mesa : 1160.129.32216 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

La Mesa :

A Phase 3 clinical study for patients with Cardiovascular Disease

Laguna Hills : Alliance Research Centers

A clinical trial to evaluate treatments using Flow Detection System for patients with Right to Left Shunt, Patent Foramen Ovale or Atrial Septal Defect

Laguna Hills :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Lakewood :

A Phase 3 clinical study for patients with Cardiovascular Disease

Lancaster :

A Phase 3 clinical study for patients with Cardiovascular Disease

Lincoln : Clinical Trials Research

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Lincoln :

A Phase 3 clinical study for patients with Cardiovascular Disease

Lincoln : Clinical Trials Research

A Phase 3 clinical study for patients with Cardiovascular Disease

Lomita :

A Phase 3 clinical study for patients with Cardiovascular Disease

Long Beach : Acorda Investigational Site Updated

A clinical trial seeking patients for a research study for the treatment of Post-Ischemic Stroke

Long Beach :

A Phase 3 clinical study for patients with Cardiovascular Disease

Long Beach : 1160.189.11218 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Los Alamitos : 1160.129.32039 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Los Angeles : UCLA Medical Center

A clinical research study of MultiStem and Placebo for the treatment of Ischemic Stroke

Los Angeles :

A clinical trial seeking patients for a research study for the treatment of Sialorrhea

Los Angeles : Pamela Roberts

A clinical trial to evaluate treatments for patients with Stroke

Los Angeles : UCLA Medical Center

A clinical trial to evaluate treatments using Flow Detection System for patients with Right to Left Shunt, Patent Foramen Ovale or Atrial Septal Defect

Los Angeles :

A Phase 3 clinical study for patients with Cardiovascular Disease

Los Angeles : Stroke Center

Patients are needed to participate in a clinical research study evaluating 3K3A-APC and Placebo for the treatment of Ischemic Stroke

Los Angeles : Cedars-Sinai Medical Center

Patients are needed to participate in a clinical research study for the treatment of Atherosclerotic Disease, Carotid

Los Gatos : Richard S. Cherlin, MD

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Los Gatos : Richard S. Cherlin, MD

A Phase 3 clinical study for patients with Cardiovascular Disease

Mission Hills : Facey Medical Foundation

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Mission Hills : Facey Medical Foundation

A Phase 3 clinical study for patients with Cardiovascular Disease

Murrieta :

A Phase 3 clinical study for patients with Cardiovascular Disease

Newport Beach : Hoag Memorial Hospital Presbyterian

A Phase 2 clinical study for patients with Stroke

Newport Beach : Hoag Hospital

Patients are needed to participate in a clinical research study evaluating Penumbra System with Separator 3D and Penumbra System alone for the treatment of Acute Ischemic Stroke From Large Vessel Occlusion

Northridge : 1160.129.32326 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Northridge :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Orange : 1160.129.32420 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Orange :

A Phase 3 clinical study for patients with Cardiovascular Disease

Palmdale :

A Phase 3 clinical study for patients with Cardiovascular Disease

Palo Alto : 1160.129.32329 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Paramount :

A Phase 3 clinical study for patients with Cardiovascular Disease

Pasadena : Huntington Memorial Hospital Stroke Center

A Phase 2 clinical study for patients with Stroke

Pomona : 1160.129.32352 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Pomona :

A Phase 3 clinical study for patients with Cardiovascular Disease

Poway :

A Phase 3 clinical study for patients with Cardiovascular Disease

Rancho Cucamonga :

A Phase 3 clinical study for patients with Cardiovascular Disease

Rancho Mirage : 1160.129.32170 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Redondo Beach :

A Phase 3 clinical study for patients with Cardiovascular Disease

Riverside :

A Phase 3 clinical study for patients with Cardiovascular Disease

Roseville :

A Phase 3 clinical study for patients with Cardiovascular Disease

Sacramento :

A Phase 3 clinical study for patients with Cardiovascular Disease

San Diego : San Diego Family Care

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

San Diego :

A clinical trial seeking patients for a research study for the treatment of Sialorrhea

San Diego : 1160.129.32017 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

San Diego :

A Phase 3 clinical study for patients with Cardiovascular Disease

San Francisco : California Pacific Medical Center Research Institute

A Phase 2 clinical study for patients with Stroke

San Francisco : University of California San Francisco

Patients are needed to participate in a clinical research study for the treatment of Atherosclerotic Disease, Carotid

San Jose :

A Phase 3 clinical study for patients with Cardiovascular Disease

San Luis Obispo :

A Phase 3 clinical study for patients with Cardiovascular Disease

San Ramon :

A Phase 3 clinical study for patients with Cardiovascular Disease

Santa Ana : 1160.129.32370 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Santa Ana :

A Phase 3 clinical study for patients with Cardiovascular Disease

Santa Monica : Coastal Biomedical Research, Inc.

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Santa Monica : Coastal Biomedical Research, Inc.

A Phase 3 clinical study for patients with Cardiovascular Disease

Santa Rosa :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Spring Valley : Encompass Clinical Research

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Stanford : Stanford University

A clinical research study of MultiStem and Placebo for the treatment of Ischemic Stroke

Stanford : Stanford University Medical Center

A clinical trial to evaluate treatments using RP-1127 (Glyburide for Injection) for patients with Ischemic Stroke or Malignant Edema

Stockton : St. Joseph's Medical Associates

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Stockton :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Stockton : St. Joseph's Medical Associates

A Phase 3 clinical study for patients with Cardiovascular Disease

Sylmar :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Temecula : 1160.129.32167 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Thousand Oaks : Westlake Medical Research

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Thousand Oaks : Westlake Medical Research

A Phase 3 clinical study for patients with Cardiovascular Disease

Thousand Oaks :

A Phase 3 clinical study for patients with Cardiovascular Disease

Torrance : Los Angeles Biomedical Research Institute at Harbor - UCLA Medical Center

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Torrance : Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Torrance : Harbor - UCLA Medical Center

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Torrance :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Torrance : 1160.129.32381 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Torrance : Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center

A Phase 3 clinical study for patients with Cardiovascular Disease

Torrance :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Tustin : Orange County Research Center

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Tustin :

A Phase 3 clinical study for patients with Cardiovascular Disease

Ventura : 1160.129.32196 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Visalia : 1160.129.32104 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Vista :

A Phase 3 clinical study for patients with Cardiovascular Disease

Westlake Village :

A Phase 3 clinical study for patients with Cardiovascular Disease

Whittier :

A Phase 3 clinical study for patients with Cardiovascular Disease

Colorado

Arvada :

A Phase 3 clinical study for patients with Cardiovascular Disease

Aurora : 1160.129.32031 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Aurora : University of Colorado

A clinical trial to evaluate treatments using Flow Detection System for patients with Right to Left Shunt, Patent Foramen Ovale or Atrial Septal Defect

Colorado Springs : Lynn Institute of the Rockies

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Colorado Springs : Lynn Institute of the Rockies

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Colorado Springs : Acorda Investigational Site Updated

A clinical trial seeking patients for a research study for the treatment of Post-Ischemic Stroke

Colorado Springs : 1160.129.32021 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Colorado Springs : 1160.129.32204 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Colorado Springs : Lynn Institute of the Rockies

A Phase 3 clinical study for patients with Cardiovascular Disease

Colorado Springs : Lynn Institute of the Rockies

A Phase 3 clinical study for patients with Cardiovascular Disease

Colorado Springs :

A Phase 3 clinical study for patients with Cardiovascular Disease

Denver : Lynn Institute of Denver

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Denver :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Denver :

A clinical trial seeking patients for a research study for the treatment of Sialorrhea

Denver : 1160.129.32393 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Denver :

A Phase 3 clinical study for patients with Cardiovascular Disease

Denver : Lynn Institute of Denver

A Phase 3 clinical study for patients with Cardiovascular Disease

Denver : Swedish Medical Center

Patients are needed to participate in a clinical research study evaluating Penumbra System with Separator 3D and Penumbra System alone for the treatment of Acute Ischemic Stroke From Large Vessel Occlusion

Glenwood Springs :

A Phase 3 clinical study for patients with Cardiovascular Disease

Littleton : 1160.129.32317 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Longmont :

A Phase 3 clinical study for patients with Cardiovascular Disease

Wheat Ridge :

A Phase 3 clinical study for patients with Cardiovascular Disease

Connecticut

Fairfield : Associated Neurologists of Southern Connecticut, P.C. Updated

BOTOX® Treatment in Pediatric Lower Limb Spasticity

Fairfield : Associated Neurologists of Southern Connecticut, P.C. Updated

BOTOX® Treatment in Pediatric Upper Limb Spasticity

Stamford : Stamford Therapeutics Consortium

Are You at Risk for a Heart Attack or Stroke?

Bridgeport : 1160.129.32268 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Bridgeport : 1160.129.32193 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Bridgeport : 1160.129.32233 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Danbury : Acorda Investigational Site Updated

A clinical trial seeking patients for a research study for the treatment of Post-Ischemic Stroke

Danbury :

A Phase 3 clinical study for patients with Cardiovascular Disease

Fairfield : Acorda Investigational Site Updated

A clinical trial seeking patients for a research study for the treatment of Post-Ischemic Stroke

Fairfield :

A Phase 3 clinical study for patients with Pediatrics, Muscle Spasticity, Cerebral Palsy or Stroke

Hartford : Hartford Hospital

Patients are needed to participate in a clinical research study evaluating Penumbra System with Separator 3D and Penumbra System alone for the treatment of Acute Ischemic Stroke From Large Vessel Occlusion

Middlebury :

A Phase 3 clinical study for patients with Cardiovascular Disease

Milford :

A Phase 3 clinical study for patients with Cardiovascular Disease

New Haven : Yale University School of Medicine

A clinical trial to evaluate treatments using RP-1127 (Glyburide for Injection) for patients with Ischemic Stroke or Malignant Edema

Norwalk : 1160.129.32074 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Norwalk : 1160.129.32303 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Norwalk :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Shelton : 1160.129.32152 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Stamford : Stamford Therapeutics Consortium

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Stamford :

A Phase 3 clinical study for patients with Cardiovascular Disease

Stamford : Stamford Therapeutics Consortium

A Phase 3 clinical study for patients with Cardiovascular Disease

Stamford :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Trumbull :

A Phase 3 clinical study for patients with Cardiovascular Disease

Trumbull :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Delaware

Newark : 1160.129.32066 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

District of Columbia

Washington :

A clinical trial seeking patients for a research study for the treatment of Sialorrhea

Washington : 1160.129.32202 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Washington : 1160.129.32414 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Washington : 1160.129.32314 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Florida

Bradenton : Meridien Research

Cardiac Conditions

Brooksville : Meridien Research

Cardiac Conditions

Gulf Breeze : NW FL Clinical Research Group, LLC Updated

BOTOX® Treatment in Pediatric Lower Limb Spasticity

Gulf Breeze : NW FL Clinical Research Group, LLC Updated

BOTOX® Treatment in Pediatric Upper Limb Spasticity

Lakeland : Meridien Research

Cardiac Conditions

Orlando : Pediatric Neurology, PA Updated

BOTOX® Treatment in Pediatric Lower Limb Spasticity

Orlando : Pediatric Neurology, PA Updated

BOTOX® Treatment in Pediatric Upper Limb Spasticity

Tampa : University of South Florida - Tampa General Hospital

A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.

Tampa : Meridien Research

Cardiac Conditions

Atlantis : ACRC - Cardiology

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Atlantis : Acorda Investigational Site Updated

A clinical trial seeking patients for a research study for the treatment of Post-Ischemic Stroke

Atlantis : ACRC - Cardiology

A Phase 3 clinical study for patients with Cardiovascular Disease

Atlantis :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Aventura : 1160.129.32270 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Boca Raton :

A clinical trial seeking patients for a research study for the treatment of Sialorrhea

Boca Raton :

A Phase 3 clinical study for patients with Cardiovascular Disease

Boynton Beach :

A Phase 3 clinical study for patients with Cardiovascular Disease

Bradenton :

A Phase 3 clinical study for patients with Cardiovascular Disease

Bradenton : 1160.189.10220 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Brandon : 1160.129.32144 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Brandon :

A Phase 3 clinical study for patients with Cardiovascular Disease

Brooksville : Meridien Research

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Clearwater : Gulf Coast Endocrine and Diabetes Center

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Clearwater :

A Phase 3 clinical study for patients with Cardiovascular Disease

Clearwater : GulfCoast Endocrine and Diabetes Center

A Phase 3 clinical study for patients with Cardiovascular Disease

Clearwater :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Coral Springs :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Crystal River :

A Phase 3 clinical study for patients with Cardiovascular Disease

Cutler Bay :

A Phase 3 clinical study for patients with Cardiovascular Disease

Daytona Beach :

A Phase 3 clinical study for patients with Cardiovascular Disease

Delray Beach : 1160.129.32048 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Edgewater :

A Phase 3 clinical study for patients with Cardiovascular Disease

Fleming Island :

A Phase 3 clinical study for patients with Cardiovascular Disease

Fort Lauderdale : The Office of Alan Graff, MD, PA

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Fort Lauderdale : The Center for Diabetes and Endocrine Care

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Fort Lauderdale : The Office of Maxine E. Hamilton, MD, PA

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Fort Lauderdale : Invesclinic, LLC

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Fort Lauderdale : Broward Health Medical Center

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Fort Lauderdale : Invesclinic, LLC

A Phase 3 clinical study for patients with Cardiovascular Disease

Fort Lauderdale :

A Phase 3 clinical study for patients with Cardiovascular Disease

Fort Lauderdale : The Office of Maxine E. Hamilton, MD, PA

A Phase 3 clinical study for patients with Cardiovascular Disease

Fort Lauderdale : The Office of Dr. Alan Graff, MD, PA

A Phase 3 clinical study for patients with Cardiovascular Disease

Fort Myers :

A Phase 3 clinical study for patients with Cardiovascular Disease

Gainesville : 1160.129.32132 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Hallandale : 1160.129.32409 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Hialeah : Acorda Investigational Site Updated

A clinical trial seeking patients for a research study for the treatment of Post-Ischemic Stroke

Hialeah :

A Phase 3 clinical study for patients with Cardiovascular Disease

Hollywood : 1160.129.32318 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Hollywood :

A Phase 3 clinical study for patients with Cardiovascular Disease

Jacksonville : River City Clinical Research

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Jacksonville : Jacksonville Center for Clinical Research

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Jacksonville : University of Florida, Jacksonville

A clinical trial to evaluate treatments using RP-1127 (Glyburide for Injection) for patients with Ischemic Stroke or Malignant Edema

Jacksonville :

A Phase 3 clinical study for patients with Cardiovascular Disease

Jacksonville : Jacksonville Center for Clinical Research

A Phase 3 clinical study for patients with Cardiovascular Disease

Jacksonville Beach :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Jupiter : 1160.129.32090 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Lakeland : Meridien Research

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Lakeland : 1160.129.32079 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Largo :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Melbourne : Accelovance

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Melbourne : Accelovance

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Miami : University of Miami

A clinical research study of MultiStem and Placebo for the treatment of Ischemic Stroke

Miami : International Research Associates, LLC

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Miami : Kendall South Medical Center, Inc.

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Miami : Pharmax Research Clinic, Inc.

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Miami : Research Institute of South Florida, Inc.

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Miami : South Florida Research Group, LLC

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Miami : Team Medical Research

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Miami : Acorda Investigational Site Updated

A clinical trial seeking patients for a research study for the treatment of Post-Ischemic Stroke

Miami : Acorda Investigational Site Updated

A clinical trial seeking patients for a research study for the treatment of Post-Ischemic Stroke

Miami : 1160.129.32312 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Miami : 1160.129.32222 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Miami : 1160.129.32309 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Miami : 1160.129.32399 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Miami : Pharmax Research Clinic, Inc.

A Phase 3 clinical study for patients with Cardiovascular Disease

Miami :

A Phase 3 clinical study for patients with Cardiovascular Disease

Miami : Research Institute of South Florida, Inc.

A Phase 3 clinical study for patients with Cardiovascular Disease

Miami : International Research Associates, LLC

A Phase 3 clinical study for patients with Cardiovascular Disease

Miami : South Florida Research Group, LLC

A Phase 3 clinical study for patients with Cardiovascular Disease

Miami : University of Miami

Patients are needed to participate in a clinical research study for the treatment of Atherosclerotic Disease, Carotid

Miami Springs : Ocean Blue Medical Research Center, Inc.

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Miami Springs : Ocean Blue Medical Research Center, Inc.

A Phase 3 clinical study for patients with Cardiovascular Disease

Miramar Beach : 1160.129.32125 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Naples : 1160.129.32383 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

New Port Richey :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

New Smyrna Beach : 1160.129.32005 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

New Smyrna Beach :

A Phase 3 clinical study for patients with Cardiovascular Disease

Oakland Park : Invesclinic, LLC d/b/a SouthEast Medical Centre

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Oakland Park : Invesclinic, LLC d/b/a SouthEast Medical Centre

A Phase 3 clinical study for patients with Cardiovascular Disease

Oldsmar :

A Phase 3 clinical study for patients with Cardiovascular Disease

Orlando : Florida Hospital Orlando

A clinical research study of MultiStem and Placebo for the treatment of Ischemic Stroke

Orlando : Omega Research Consultants, LLC

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Orlando : Omega Research Consultants, LLC

A Phase 3 clinical study for patients with Cardiovascular Disease

Orlando :

A Phase 3 clinical study for patients with Cardiovascular Disease

Pembroke Pines : A&R Research Group, LLC

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Pembroke Pines : 1160.129.32310 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Pembroke Pines :

A Phase 3 clinical study for patients with Cardiovascular Disease

Pensacola : 1160.129.32239 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Pensacola :

Patients are needed to participate in a clinical research study of Nuedexta (DM 20 mg/Q 10 mg) to evaluate Pseudobulbar Affect (PBA), Stroke, Dementia or Traumatic Brain Injury (TBI)

Pinellas Park : DMI Research, Inc.

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Pinellas Park :

A Phase 3 clinical study for patients with Cardiovascular Disease

Port Charlotte :

A clinical trial seeking patients for a research study for the treatment of Sialorrhea

Port Charlotte :

A Phase 3 clinical study for patients with Cardiovascular Disease

Rockledge : 1160.129.32259 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Safety Harbor :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Sarasota : 1160.129.32248 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Sarasota : 1160.129.32313 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Sarasota : 1160.129.32006 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Sarasota : Sarasota Memorial Hospital

A Phase 2 clinical study for patients with Stroke

Sarasota :

A Phase 3 clinical study for patients with Cardiovascular Disease

Sarasota :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Seminole : The Office of Bridget Bellingar, DO

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Seminole : 1160.129.32020 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

South Miami :

A Phase 3 clinical study for patients with Cardiovascular Disease

St. Cloud :

A Phase 3 clinical study for patients with Cardiovascular Disease

St. Petersburg : Meridien Research

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

St. Petersburg : 1160.129.32402 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

St. Petersburg : 1160.129.32116 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

St. Petersburg : 1160.129.32057 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

St. Petersburg :

A Phase 3 clinical study for patients with Cardiovascular Disease

Summerfield :

A Phase 3 clinical study for patients with Cardiovascular Disease

Sunrise : Acorda Investigational Site Updated

A clinical trial seeking patients for a research study for the treatment of Post-Ischemic Stroke

Tallahassee : 1160.129.32064 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Tamarac : Concept Clinical Trials, Llc

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Tamarac : Concept Clinical Trials, LLC

A Phase 3 clinical study for patients with Cardiovascular Disease

Tamarac :

A Phase 3 clinical study for patients with Cardiovascular Disease

Tampa : 1160.129.32277 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Tampa :

A Phase 3 clinical study for patients with Cardiovascular Disease

Vero Beach : Acorda Investigational Site Updated

A clinical trial seeking patients for a research study for the treatment of Post-Ischemic Stroke

Vero Beach : 1160.129.32342 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Wellington : 1160.129.32037 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

West Palm Beach : Metabolic Research Institute, Inc.

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

West Palm Beach :

A Phase 3 clinical study for patients with Cardiovascular Disease

West Palm Beach : Metabolic Research Institute, Inc.

A Phase 3 clinical study for patients with Cardiovascular Disease

Winter Haven : Clinical Research of Central Flordia

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Winter Haven :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Winter Haven :

A Phase 3 clinical study for patients with Cardiovascular Disease

Winter Park :

A Phase 3 clinical study for patients with Cardiovascular Disease

Georgia

Columbus : Columbus Regional Research Institute

Had a Blocked Artery? Worried about a Heart Attack or Stroke?

Athens :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Athens :

A Phase 3 clinical study for patients with Cardiovascular Disease

Atlanta : Shepherd Rehabilitation Center

A clinical research study of NBS-guided rTMS and Sham rTMS for the treatment of Stroke

Atlanta : Atlanta Diabetes Associates

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Atlanta : 1160.129.32302 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Atlanta : Emory University at Grady Memorial Hospital

A clinical trial seeking patients for an Ischemic Stroke treatment research study

Atlanta : Atlanta Diabetes Associates

A Phase 3 clinical study for patients with Cardiovascular Disease

Atlanta :

A Phase 3 clinical study for patients with Cardiovascular Disease

Atlanta : Grady Health System

Patients are needed to participate in a clinical research study evaluating Penumbra System with Separator 3D and Penumbra System alone for the treatment of Acute Ischemic Stroke From Large Vessel Occlusion

Augusta : Georgia Regents University

A clinical research study of MultiStem and Placebo for the treatment of Ischemic Stroke

Augusta :

A Phase 3 clinical study for patients with Cardiovascular Disease

Calhoun :

A Phase 3 clinical study for patients with Cardiovascular Disease

Columbus : 1160.189.10225 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Conyers :

A Phase 3 clinical study for patients with Cardiovascular Disease

Cumming :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Cumming : 1160.129.32185 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Decatur : Neurostudies.Net, LLC

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Decatur : Acorda Investigational Site Updated

A clinical trial seeking patients for a research study for the treatment of Post-Ischemic Stroke

Decatur : 1160.129.32083 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Decatur : Neurostudies.net, LLC

A Phase 3 clinical study for patients with Cardiovascular Disease

Decatur :

A Phase 3 clinical study for patients with Cardiovascular Disease

Duluth :

A Phase 3 clinical study for patients with Cardiovascular Disease

Dunwoody :

A Phase 3 clinical study for patients with Cardiovascular Disease

Macon : 1160.129.32401 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Norcross : In-Quest Medical Research, LLC

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Norcross : In-Quest Medical Research, LLC

A Phase 3 clinical study for patients with Cardiovascular Disease

Norcross :

A Phase 3 clinical study for patients with Cardiovascular Disease

Roswell :

A Phase 3 clinical study for patients with Cardiovascular Disease

Suwanee :

A Phase 3 clinical study for patients with Cardiovascular Disease

Tucker :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Hawaii

Honolulu :

A Phase 3 clinical study for patients with Cardiovascular Disease

Idaho

Blackfoot : Elite Clinical Trials, LLLP

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Boise :

A Phase 3 clinical study for patients with Cardiovascular Disease

Caldwell : St. Luke's Idaho Cardiology Associates

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Caldwell : St. Luke's Idaho Cardiology Associates

A Phase 3 clinical study for patients with Cardiovascular Disease

Coeur d'Alene : 1160.129.32096 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Coeur d'Alene :

A Phase 3 clinical study for patients with Cardiovascular Disease

Meridian :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Nampa :

A Phase 3 clinical study for patients with Cardiovascular Disease

Illinois

Chicago : Rehab Institute of Chicago Updated

BOTOX® Treatment in Pediatric Lower Limb Spasticity

Addison :

A Phase 3 clinical study for patients with Cardiovascular Disease

Arlington Heights : 1160.129.32283 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Arlington Heights :

A Phase 3 clinical study for patients with Cardiovascular Disease

Belleville : 1160.129.32071 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Carbondale : 1160.129.32375 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Chicago : Northwestern University

A clinical research study of MultiStem and Placebo for the treatment of Ischemic Stroke

Chicago : Rehabilitation Institute of Chicago

A clinical research study of NBS-guided rTMS and Sham rTMS for the treatment of Stroke

Chicago :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Chicago : 1160.129.32298 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Chicago : 1160.129.32065 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Chicago : 1160.129.32412 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Chicago : 1160.129.32044 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Chicago : 1160.129.32293 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Chicago : 1160.129.32354 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Chicago : 1160.129.32103 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Chicago : Rush University Medical Center

A clinical trial to evaluate treatments using Flow Detection System for patients with Right to Left Shunt, Patent Foramen Ovale or Atrial Septal Defect

Chicago : Northwestern Memorial Hospital

A clinical trial to evaluate treatments using RP-1127 (Glyburide for Injection) for patients with Ischemic Stroke or Malignant Edema

Chicago :

A Phase 3 clinical study for patients with Cardiovascular Disease

Chicago : Stroke Center

Patients are needed to participate in a clinical research study evaluating 3K3A-APC and Placebo for the treatment of Ischemic Stroke

Chicago : Northwestern University

Patients are needed to participate in a clinical research study for the treatment of Atherosclerotic Disease, Carotid

Evanston : Evanston Premier Healthcare Research, LLC

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Evanston :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Evanston : Evanston Premier Healthcare Research, LLC

A Phase 3 clinical study for patients with Cardiovascular Disease

Evanston :

A Phase 3 clinical study for patients with Cardiovascular Disease

Evergreen Park :

A Phase 3 clinical study for patients with Cardiovascular Disease

Hazel Crest :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Hinsdale : 1160.129.32117 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Maywood :

A Phase 3 clinical study for patients with Cardiovascular Disease

Melrose Park :

A Phase 3 clinical study for patients with Cardiovascular Disease

Morton : 1160.129.32133 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Morton :

A Phase 3 clinical study for patients with Cardiovascular Disease

Naperville :

A Phase 3 clinical study for patients with Cardiovascular Disease

Quincy :

A Phase 3 clinical study for patients with Cardiovascular Disease

Rockford :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Rockford :

A Phase 3 clinical study for patients with Cardiovascular Disease

Springfield :

A Phase 3 clinical study for patients with Cardiovascular Disease

Winfield : 1160.129.32391 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Indiana

Anderson : Community Clinical Research Center

A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events with Ticagrelor Compared to Aspirin (ASA) in Patients with Acute Ischaemic Stroke or TIA

Anderson : Community Clinical Research Center

Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)

Avon : Acorda Investigational Site Updated

A clinical trial seeking patients for a research study for the treatment of Post-Ischemic Stroke

Bloomington :

A Phase 3 clinical study for patients with Cardiovascular Disease

Brownsburg : Investigators Research Group, LLC

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Brownsburg : 1160.129.32001 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Brownsburg : Investigators Research Group, LLC

A Phase 3 clinical study for patients with Cardiovascular Disease

Brownsburg :

A Phase 3 clinical study for patients with Cardiovascular Disease

Carmel :

A clinical trial seeking patients for a research study for the treatment of Sialorrhea

Evansville : MediSphere Medical Research Center, LLC

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Evansville : Clinical Research Advantage, Inc. IP Shipment and Research Site

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Evansville : Deaconess Clinic Mt. Pleasant

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Evansville : Deaconess Clinic Downtown

A Phase 3 clinical study for patients with Cardiovascular Disease

Evansville : Deaconess Clinic Mt. Pleasant

A Phase 3 clinical study for patients with Cardiovascular Disease

Evansville : Clinical Research Advantage, Inc.

A Phase 3 clinical study for patients with Cardiovascular Disease

Fort Wayne : 1160.129.32376 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Franklin : American Health Network of Indiana LLC

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Franklin : Acorda Investigational Site Updated

A clinical trial seeking patients for a research study for the treatment of Post-Ischemic Stroke

Greenfield : American Health Network of Indiana, LLC

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Indianapolis : Indiana University Indianapolis

A clinical research study of NBS-guided rTMS and Sham rTMS for the treatment of Stroke

Indianapolis : 1160.129.32245 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Indianapolis : Clarian Health / Methodist Hospital

A clinical trial to evaluate treatments using LAAx TigerPaw System for patients with Stroke

La Porte : 1160.129.32320 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Lafayette :

A Phase 3 clinical study for patients with Cardiovascular Disease

Merrillville :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Muncie : American Health Network of IN LLC

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Muncie : American Health Network of Indiana, LLC

A Phase 3 clinical study for patients with Cardiovascular Disease

Munster : 1160.129.32046 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

South Bend :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

South Bend : 1160.129.32327 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Valparaiso : Buynak Clinical Research, P.C.

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Valparaiso : Buynak Clinical Research, P.C.

A Phase 3 clinical study for patients with Cardiovascular Disease

Valparaiso :

A Phase 3 clinical study for patients with Cardiovascular Disease

Iowa

Council Bluffs : West Broadway Clinic

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Council Bluffs : Clinical Research Advantage, Inc./Ridge Family Practice (IP Shipment and Research Site)

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Council Bluffs : West Broadway Clinic

A Phase 3 clinical study for patients with Cardiovascular Disease

Iowa City : University of Iowa College of Public Health - Preventive Intervention Center

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Iowa City :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Iowa City : 1160.129.32411 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Iowa City :

A Phase 3 clinical study for patients with Cardiovascular Disease

Iowa City : University of Iowa, University of Hospitals and Clinics - Division

A Phase 3 clinical study for patients with Cardiovascular Disease

Iowa City : University of Iowa College of Public Health - Preventive Intervention Center

A Phase 3 clinical study for patients with Cardiovascular Disease

West Des Moines : 1160.129.32089 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

West Des Moines :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Kansas

Wichita : Via Christi Research

THERAPY: Assess the Penumbra System to Treat Acute Stroke

Kansas City : Stroke Center

Patients are needed to participate in a clinical research study evaluating 3K3A-APC and Placebo for the treatment of Ischemic Stroke

Lenexa :

A Phase 3 clinical study for patients with Cardiovascular Disease

Newton : Heartland Research Associates, LLC

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Overland Park : Midwest Heart & Vascular Specialists, LLC

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Overland Park : 1160.129.32029 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Overland Park :

A Phase 3 clinical study for patients with Cardiovascular Disease

Overland Park : Midwest Heart & Vascular Specialists, LLC

A Phase 3 clinical study for patients with Cardiovascular Disease

Overland Park :

A Phase 3 clinical study for patients with Muscle Spasticity or Stroke

Shawnee Mission : GTC Research

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Shawnee Mission :

A Phase 3 clinical study for patients with Cardiovascular Disease

Shawnee Mission : Women's & Family Care D.B.A. GTC Research

A Phase 3 clinical study for patients with Cardiovascular Disease

Topeka :

A Phase 3 clinical study for patients with Cardiovascular Disease

Wichita :

A Phase 3 clinical study for patients with Cardiovascular Disease

Kentucky

Lexington : Baptist Health Clinical Research Center & Lexington Cardiac Research Foundation

Mild and Rapidly Improving Stroke Study (MaRISS), Get With The Guidelines-Stroke Research Registry.

Lexington : Baptist Health Clinical Research Center & Lexington Cardiac Research Foundation

PROSPER (Patient-centered Research into Outcomes Stroke patients Prefer and Effectiveness Research) is a three year research project to create a national, sustainable model to improve decision-making and patient-centered stroke outcomes through comparative effectiveness research.

Lexington : University of Kentucky Chandler Medical Center

Rehabilitation: Have You or Someone You Know Experienced a Stroke?

Lexington : University of Kentucky Chandler Medical Center

Stroke: Research Study Have You or Someone You Know Experienced a Stroke?

Lexington : Baptist Health Clinical Research Center & Lexington Cardiac Research Foundation

Systematic Evaluation of Patients TReated with Neurothrombectomy Devices for AcuTe Ischemic Stroke (STRATIS) Registry

Elizabethtown :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Elizabethtown : 1160.129.32025 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Elizabethtown :

A Phase 3 clinical study for patients with Cardiovascular Disease

Lexington : University of Kentucky Medical Center

A clinical research study of MultiStem and Placebo for the treatment of Ischemic Stroke

Lexington : The Research Group of Lexington, LLC

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Lexington :

A Phase 3 clinical study for patients with Cardiovascular Disease

Lexington : The Research Group of Lexington, LLC

A Phase 3 clinical study for patients with Cardiovascular Disease

Lexington : 1160.189.10217 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Louisville : University of Louisville

A clinical research study of MultiStem and Placebo for the treatment of Ischemic Stroke

Louisville : L-MARC

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Louisville :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Louisville : 1160.129.32392 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Louisville : University of Louisville Hospital

A clinical trial to evaluate treatments using RP-1127 (Glyburide for Injection) for patients with Ischemic Stroke or Malignant Edema

Louisville : University of Louisville

A Phase 2 clinical study for patients with Stroke

Louisville :

A Phase 3 clinical study for patients with Cardiovascular Disease

Louisville : L-MARC

A Phase 3 clinical study for patients with Cardiovascular Disease

Madisonville : 1160.129.32422 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Mount Sterling : 1160.129.32188 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Owensboro :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Owensboro : 1160.129.32059 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Owensboro :

A Phase 3 clinical study for patients with Cardiovascular Disease

Paducah :

A Phase 3 clinical study for patients with Cardiovascular Disease

Louisiana

Alexandria : Alexandria Cardiology Clinic

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Alexandria : 1160.129.32176 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Alexandria : 1160.189.10259 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Baton Rouge : 1160.129.32286 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Bossier City : 1160.129.32201 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Hammond : 1160.129.32045 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Kenner : 1160.129.32271 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Lake Charles : 1160.129.32235 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Mer Rouge :

A Phase 3 clinical study for patients with Cardiovascular Disease

Monroe :

A Phase 3 clinical study for patients with Cardiovascular Disease

New Orleans : 1160.129.32274 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Shreveport :

A Phase 3 clinical study for patients with Cardiovascular Disease

Slidell : 1160.129.32164 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Maine

Biddeford : 1160.129.32122 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Biddeford :

A Phase 3 clinical study for patients with Cardiovascular Disease

Rockport :

A Phase 3 clinical study for patients with Cardiovascular Disease

Scarborough : Maine Medical Center

A clinical trial to evaluate treatments using RP-1127 (Glyburide for Injection) for patients with Ischemic Stroke or Malignant Edema

Maryland

Annapolis : Anne Arundel Medical Center

A clinical research study of rt-PA for the treatment of Stroke

Annapolis : 1160.129.32226 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Baltimore :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Baltimore : The Johns Hopkins Hospital

A clinical research study of rt-PA for the treatment of Stroke

Baltimore : Johns Hopkins Bayview Medical Center

A clinical research study of rt-PA for the treatment of Stroke

Baltimore :

A clinical trial seeking patients for a research study for the treatment of Sialorrhea

Baltimore : University of Maryland School of Medicine

A clinical trial to evaluate treatments using RP-1127 (Glyburide for Injection) for patients with Ischemic Stroke or Malignant Edema

Baltimore :

A Phase 3 clinical study for patients with Cardiovascular Disease

Clinton : 1160.129.32421 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Columbia : 1160.129.32388 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Cumberland :

A Phase 3 clinical study for patients with Cardiovascular Disease

Elkridge :

A clinical trial seeking patients for a research study for the treatment of Sialorrhea

Hagerstown :

A Phase 3 clinical study for patients with Cardiovascular Disease

Lutherville :

A Phase 3 clinical study for patients with Cardiovascular Disease

Oxon Hill : MD Medical Research

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Oxon Hill :

A Phase 3 clinical study for patients with Cardiovascular Disease

Randallstown :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Salisbury : 1160.129.32155 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Salisbury : 1160.129.32148 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Wheaton :

A Phase 3 clinical study for patients with Cardiovascular Disease

Massachusetts

Boston : Boston University

A clinical research study of MultiStem and Placebo for the treatment of Ischemic Stroke

Boston : Spaulding Rehabilitation Hospital

A clinical research study of NBS-guided rTMS and Sham rTMS for the treatment of Stroke

Boston : Acorda Investigational Site Updated

A clinical trial seeking patients for a research study for the treatment of Post-Ischemic Stroke

Boston : Tufts Medical Center

A clinical trial to evaluate treatments using Flow Detection System for patients with Right to Left Shunt, Patent Foramen Ovale or Atrial Septal Defect

Boston : Massachusetts General Hospital

A clinical trial to evaluate treatments using RP-1127 (Glyburide for Injection) for patients with Ischemic Stroke or Malignant Edema

Boston : Stroke Center

Patients are needed to participate in a clinical research study evaluating 3K3A-APC and Placebo for the treatment of Ischemic Stroke

Boston : Tufts Medical Center

Patients are needed to participate in a clinical research study for the treatment of Atherosclerotic Disease, Carotid

Boston : Beth Israel Deaconess Medical Center

Patients are needed to participate in a clinical research study for the treatment of Atherosclerotic Disease, Carotid

Boston : Prof. Samuel Goldhaber

Patients are needed to participate in a clinical research study for the treatment of Atrial Fibrillation

Brighton : 1160.129.32382 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Brockton :

A Phase 3 clinical study for patients with Cardiovascular Disease

Charlestown : Myomo Inc

A clinical trial seeking patients for a research study for the treatment of Stroke

Fall River :

A Phase 3 clinical study for patients with Cardiovascular Disease

Haverhill :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Hyannis :

A Phase 3 clinical study for patients with Cardiovascular Disease

Methuen : ActivMed Practices and Research, Inc.

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Newton : 1160.129.32289 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Worcester : UMASS Memorial Medical Center

A clinical trial to evaluate treatments using RP-1127 (Glyburide for Injection) for patients with Ischemic Stroke or Malignant Edema

Worcester :

A Phase 3 clinical study for patients with Cardiovascular Disease

Michigan

Alpena : 1160.129.32036 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Alpena :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Ann Arbor : St. Joseph Mercy Health System

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Ann Arbor :

A Phase 3 clinical study for patients with Cardiovascular Disease

Ann Arbor : St. Joseph Mercy Health System (Drug shipment Only)

A Phase 3 clinical study for patients with Cardiovascular Disease

Bay City : 1160.129.32234 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Bingham Farms :

A Phase 3 clinical study for patients with Cardiovascular Disease

Bingham Farms : Quest Research Institute

A Phase 3 clinical study for patients with Cardiovascular Disease

Chelsea :

A Phase 3 clinical study for patients with Cardiovascular Disease

Detroit : Henry Ford Health System

A clinical research study of MultiStem and Placebo for the treatment of Ischemic Stroke

Detroit :

A clinical trial seeking patients for a research study for the treatment of Sialorrhea

Detroit : 1160.129.32135 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Detroit :

A Phase 3 clinical study for patients with Cardiovascular Disease

Detroit : Wayne State University

Patients are needed to participate in a clinical research study for the treatment of Atherosclerotic Disease, Carotid

East Lansing : Michigan State University

Patients are needed to participate in a clinical research study for the treatment of Atherosclerotic Disease, Carotid

Erie : 1160.129.32340 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Flint :

A Phase 3 clinical study for patients with Cardiovascular Disease

Grand Blanc : 1160.129.32264 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Grand Blanc : 1160.129.32168 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Jackson : 1160.189.10260 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Kalamazoo :

A Phase 3 clinical study for patients with Cardiovascular Disease

Lansing :

A Phase 3 clinical study for patients with Cardiovascular Disease

Marquette : 1160.129.32142 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Mount Clemens : 1160.129.32232 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Niles : 1160.129.32053 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Novi : 1160.129.32282 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Pontiac :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Pontiac : St. Joseph Mercy - Oakland

A clinical trial seeking patients for an Ischemic Stroke treatment research study

Saginaw : 1160.129.32231 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Saginaw : 1160.129.32075 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Traverse City : Medical Research Associates, Inc. at The Walk-In Clinic

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Traverse City : Medical Research Associates, Inc.

A Phase 3 clinical study for patients with Cardiovascular Disease

Troy : Troy Internal Medicine, PC

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Troy : Oakland Medical Research Center

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Troy : Oakland Medical Research Center

A Phase 3 clinical study for patients with Cardiovascular Disease

Troy : Troy Internal Medicine, PC

A Phase 3 clinical study for patients with Cardiovascular Disease

West Bloomfield :

A clinical trial seeking patients for a research study for the treatment of Sialorrhea

Ypsilanti : Michigan Heart

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Ypsilanti : Michigan Heart

A Phase 3 clinical study for patients with Cardiovascular Disease

Minnesota

St. Paul : Gillette Children's Specialty Healthcare Updated

BOTOX® Treatment in Pediatric Upper Limb Spasticity

Brooklyn Center :

A Phase 3 clinical study for patients with Cardiovascular Disease

Chaska :

A Phase 3 clinical study for patients with Cardiovascular Disease

Duluth : 1160.129.32405 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Duluth :

A Phase 3 clinical study for patients with Cardiovascular Disease

Edina :

A Phase 3 clinical study for patients with Cardiovascular Disease

Minneapolis : 1160.129.32280 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

St. Cloud : 1160.129.32190 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

St. Paul : 1160.129.32307 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

St. Paul : St. Joseph Hospital- Healtheast

Patients are needed to participate in a clinical research study evaluating Penumbra System with Separator 3D and Penumbra System alone for the treatment of Acute Ischemic Stroke From Large Vessel Occlusion

Mississippi

Biloxi : 1160.129.32339 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Jackson : University of Mississippi Medical Center

A clinical research study of MultiStem and Placebo for the treatment of Ischemic Stroke

Jackson : 1160.129.32408 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Jackson :

A Phase 3 clinical study for patients with Cardiovascular Disease

Olive Branch :

A Phase 3 clinical study for patients with Cardiovascular Disease

Port Gibson :

A Phase 3 clinical study for patients with Cardiovascular Disease

Tupelo : Cardiology Associates Research, LLC

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Tupelo : Cardiology Associates Research, LLC

A Phase 3 clinical study for patients with Cardiovascular Disease

Missouri

St. Louis : Washington University School of Medicine Updated

BOTOX® Treatment in Pediatric Lower Limb Spasticity

St. Louis : Washington University School of Medicine Updated

BOTOX® Treatment in Pediatric Upper Limb Spasticity

Clarkson Valley :

A Phase 3 clinical study for patients with Cardiovascular Disease

Florissant :

A Phase 3 clinical study for patients with Cardiovascular Disease

Hazelwood :

A Phase 3 clinical study for patients with Cardiovascular Disease

Kansas City : 1160.129.32364 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Kansas City :

A Phase 3 clinical study for patients with Cardiovascular Disease

Kansas City : Saint Luke's Lipid and Diabetes Research Center

A Phase 3 clinical study for patients with Cardiovascular Disease

St. Charles :

A Phase 3 clinical study for patients with Cardiovascular Disease

St. Joseph : 1160.129.32404 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

St. Louis :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

St. Louis :

A clinical trial seeking patients for a research study for the treatment of Sialorrhea

St. Louis : 1160.129.32297 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

St. Louis : 1160.129.32101 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

St. Louis : 1160.129.32184 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

St. Louis :

A Phase 3 clinical study for patients with Cardiovascular Disease

St. Louis : Stroke Center

Patients are needed to participate in a clinical research study evaluating 3K3A-APC and Placebo for the treatment of Ischemic Stroke

St. Louis :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Washington :

A Phase 3 clinical study for patients with Cardiovascular Disease

Montana

Billings :

A Phase 3 clinical study for patients with Cardiovascular Disease

Butte :

A Phase 3 clinical study for patients with Cardiovascular Disease

Great Falls : Acorda Investigational Site Updated

A clinical trial seeking patients for a research study for the treatment of Post-Ischemic Stroke

Kalispell : 1160.129.32165 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Kalispell :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Missoula : Montana Medical Research Inc.

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Missoula : Montana Medical Research Inc.

A Phase 3 clinical study for patients with Cardiovascular Disease

Nebraska

Bellevue :

A Phase 3 clinical study for patients with Cardiovascular Disease

Grand Island :

A Phase 3 clinical study for patients with Cardiovascular Disease

Lincoln :

A Phase 3 clinical study for patients with Cardiovascular Disease

Omaha : University of Nebraska Medical Center

A clinical research study of MultiStem and Placebo for the treatment of Ischemic Stroke

Omaha : Creighton Diabetes Center

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Omaha : 1160.129.32321 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Omaha : 1160.129.32331 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Omaha : 1160.129.32396 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Omaha :

A Phase 3 clinical study for patients with Cardiovascular Disease

Papillion : 1160.129.32199 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Nevada

Henderson :

A Phase 3 clinical study for patients with Cardiovascular Disease

Las Vegas :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Las Vegas :

A Phase 3 clinical study for patients with Cardiovascular Disease

Reno : 1160.129.32180 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Reno : 1160.129.32407 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Reno :

A Phase 3 clinical study for patients with Cardiovascular Disease

Reno : 1160.189.10249 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

New Jersey

Brick :

A Phase 3 clinical study for patients with Cardiovascular Disease

Bridgewater :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Bridgewater : 1160.129.32154 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Camden : 1160.129.32380 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Clifton : 1160.129.32423 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Edison :

A clinical trial seeking patients for a research study for the treatment of Sialorrhea

Edison :

A Phase 3 clinical study for patients with Cardiovascular Disease

Hackensack : 1160.129.32386 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Haddon Heights : 1160.129.32179 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Hammonton : 1160.129.32198 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Linden : NJ Heart

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Linden : 1160.129.32030 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Linden : NJ Heart

A Phase 3 clinical study for patients with Cardiovascular Disease

Lodi : Arysmed LLC

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Lodi : Arysmed LLC

A Phase 3 clinical study for patients with Cardiovascular Disease

Lumberton :

A Phase 3 clinical study for patients with Cardiovascular Disease

Manalapan : 1160.129.32378 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Medford :

A Phase 3 clinical study for patients with Cardiovascular Disease

Neptune : 1160.129.32049 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

New Brunswick : Rutgers Biomedical and Health Sciences - Robert Wood Johnson Medical School

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

New Brunswick : 1160.129.32389 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Ocean : 1160.129.32242 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Paterson : 1160.129.32255 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Ridgewood :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Ridgewood : 1160.129.32221 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Saddle Brook : Kessler Institute for Rehabilitation

A clinical trial to evaluate treatments using Reo Go robotic arm trainer and Conventional Therapy for patients with Acute Stroke or Paresis

Somerset : 1160.129.32099 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

South Plainfield : 1160.129.32007 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Trenton : Premier Research

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Trenton : Capital Health System

A clinical trial seeking patients for an Ischemic Stroke treatment research study

Voorhees : 1160.129.32069 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

West Orange : 1160.129.32269 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Westwood : Westwood Cardiology Associates

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Westwood : Westwood Cardiology Associates, P.A.

A Phase 3 clinical study for patients with Cardiovascular Disease

New Mexico

Albuquerque : 1160.129.32311 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Albuquerque :

A Phase 3 clinical study for patients with Cardiovascular Disease

New York

New York : Medical & Behavioral Health Research, PC

Pseudobulbar Affect (PBA) - outbursts of crying or laughing

Albany : The Endocrine Group

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Albany :

A clinical trial seeking patients for a research study for the treatment of Sialorrhea

Albany : 1160.129.32332 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Albany : The Endocrine Group

A Phase 3 clinical study for patients with Cardiovascular Disease

Bronx : 1160.129.32173 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Brooklyn : NY Scientific

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Brooklyn : 1160.129.32246 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Brooklyn :

A Phase 3 clinical study for patients with Cardiovascular Disease

Brooklyn : NY Scientific

A Phase 3 clinical study for patients with Cardiovascular Disease

Buffalo :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Buffalo : 1160.129.32395 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Buffalo : Millard Fillmore Gates Circle Hospital

A Phase 2 clinical study for patients with Stroke

Buffalo : Stroke Center

Patients are needed to participate in a clinical research study evaluating 3K3A-APC and Placebo for the treatment of Ischemic Stroke

Buffalo : Kaleida Health

Patients are needed to participate in a clinical research study evaluating Penumbra System with Separator 3D and Penumbra System alone for the treatment of Acute Ischemic Stroke From Large Vessel Occlusion

Cooperstown : 1160.129.32379 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Cortlandt Manor :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Cortlandt Manor :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Endwell :

A Phase 3 clinical study for patients with Cardiovascular Disease

Flushing : 1160.129.32387 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Freeport :

A Phase 3 clinical study for patients with Cardiovascular Disease

Glens Falls :

A Phase 3 clinical study for patients with Cardiovascular Disease

Jamaica :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Johnson City : 1160.129.32278 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Kingston :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Liverpool : SJH Cardiology Associates

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Liverpool : SJH Cardiology Associates

A Phase 3 clinical study for patients with Cardiovascular Disease

Mineola : Long Island Heart Associates

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Mineola :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Mineola : 1160.129.32038 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Mineola :

A Phase 3 clinical study for patients with Cardiovascular Disease

New Windsor : Mid Hudson Medical Research, PLLC

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

New Windsor :

A Phase 3 clinical study for patients with Cardiovascular Disease

New Windsor : Mid Hudson Medical Research, PLLC

A Phase 3 clinical study for patients with Cardiovascular Disease

New York : Columbia Cornell New York Presbyterian Hospital

A clinical research study of NBS-guided rTMS and Sham rTMS for the treatment of Stroke

New York : Weill Cornell Medical College

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

New York : New York Presbyterian Hospital/Weill Cornell Medical College Investigational Drug Pharmacy

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

New York :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

New York :

A clinical trial seeking patients for a research study for the treatment of Sialorrhea

New York : 1160.129.32110 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

New York : 1160.129.32372 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

New York : 1160.129.32361 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

New York : 1160.129.32368 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

New york : Columbia University Medical Center

A clinical trial to evaluate treatments using Flow Detection System for patients with Right to Left Shunt, Patent Foramen Ovale or Atrial Septal Defect

New York : Columbia University Medical Center

A Phase 2 clinical study for patients with Stroke

New York : Stroke Center

Patients are needed to participate in a clinical research study evaluating 3K3A-APC and Placebo for the treatment of Ischemic Stroke

New York : Gotham Cardiovascular Research PC

Patients are needed to participate in a clinical research study for the treatment of Atherosclerotic Disease, Carotid

New York : New York University School of Medicine

Patients are needed to participate in a clinical research study for the treatment of Atherosclerotic Disease, Carotid

Poughkeepsie :

A Phase 3 clinical study for patients with Cardiovascular Disease

Rochester :

A Phase 3 clinical study for patients with Cardiovascular Disease

Rosedale : Clinical Research Development Associates, LLC

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Rosedale : Clinical Research Development Associates, LLC

A Phase 3 clinical study for patients with Cardiovascular Disease

Saratoga Springs :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Stony Brook : 1160.129.32299 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Stony Brook : Stony Brook University Hospital

Patients are needed to participate in a clinical research study evaluating Penumbra System with Separator 3D and Penumbra System alone for the treatment of Acute Ischemic Stroke From Large Vessel Occlusion

Syracuse : 1160.129.32397 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Syracuse : 1160.129.32139 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

West Seneca :

A Phase 3 clinical study for patients with Cardiovascular Disease

Westfield : 1160.129.32263 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Westfield :

A Phase 3 clinical study for patients with Cardiovascular Disease

White Plains : Burke Medical Research Institute, Weill Cornell Neurology

A clinical research study of NBS-guided rTMS and Sham rTMS for the treatment of Stroke

White Plains : Acorda Investigational Site Updated

A clinical trial seeking patients for a research study for the treatment of Post-Ischemic Stroke

Williamsville : 1160.129.32016 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

North Carolina

Charlotte : PMG Research of Charlotte, LLC Updated

BOTOX® Treatment in Pediatric Lower Limb Spasticity

Charlotte : PMG Research of Charlotte, LLC Updated

BOTOX® Treatment in Pediatric Upper Limb Spasticity

Greensboro : Guilford Neurologic Associates

Do you have foot drop as a result of a stroke?

Greensboro : Guilford Neurologic Associates

Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4)

Greensboro : Guilford Neurologic Associates

Efficacy and Safety Trial of Transcranial Laser Therapy Within 24 Hours From Stroke Onset (NEST-3)

Greensboro : Guilford Neurologic Associates

Insulin Resistance Intervention After Stroke Trial (IRIS)

Greensboro : Guilford Neurologic Associates

Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial

Raleigh : PMG Research of Raleigh

Heart Attack...Stroke. Are you at risk?

Asheboro :

A Phase 3 clinical study for patients with Cardiovascular Disease

Burlington : 1160.129.32265 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Cary :

A Phase 3 clinical study for patients with Cardiovascular Disease

Charlotte : PMG Research of Charlotte

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Charlotte : Sensenbrenner Primary Care

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Charlotte : Sensenbrenner Primary Care

A Phase 3 clinical study for patients with Cardiovascular Disease

Charlotte :

A Phase 3 clinical study for patients with Cardiovascular Disease

Concord :

A Phase 3 clinical study for patients with Cardiovascular Disease

Durham : Duke University Medical Center

A clinical study for patients with Post-stroke Aphasia

Durham : Duke University Medical Center

A clinical research study of NBS-guided rTMS and Sham rTMS for the treatment of Stroke

Greensboro :

A Phase 3 clinical study for patients with Cardiovascular Disease

Greensboro : 1160.189.10244 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Harrisburg :

A Phase 3 clinical study for patients with Cardiovascular Disease

Hickory : 1160.129.32070 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Hickory : 1160.189.11257 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

High Point :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

High Point : 1160.129.32033 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Huntersville :

A Phase 3 clinical study for patients with Cardiovascular Disease

Jacksonville : 1160.129.32114 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Kannapolis : 1160.129.32251 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Lenoir : 1160.129.32072 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Lenoir :

A Phase 3 clinical study for patients with Cardiovascular Disease

Monroe :

A Phase 3 clinical study for patients with Cardiovascular Disease

Mooresville : Research Institute of the Carolinas of PiedmontHealthcare, PA

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Mooresville : Research Institute of the Carolinas of Piedmont Healthcare, PA

A Phase 3 clinical study for patients with Cardiovascular Disease

Pinehurst : 1160.129.32073 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Pinehurst :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Raleigh : 1160.129.32162 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Raleigh :

A Phase 3 clinical study for patients with Cardiovascular Disease

Salisbury :

A Phase 3 clinical study for patients with Cardiovascular Disease

Shelby :

A Phase 3 clinical study for patients with Cardiovascular Disease

Wilmington : PMG Research of Wilmington, LLC

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Wilmington :

A Phase 3 clinical study for patients with Cardiovascular Disease

Wilson : 1160.129.32215 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Winston-Salem : Wake Forest University School of Medicine

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Winston-Salem : Wake Forest University School of Medicine

A Phase 3 clinical study for patients with Cardiovascular Disease

Winston-Salem :

A Phase 3 clinical study for patients with Cardiovascular Disease

North Dakota

Bismarck : St. Alexius Medical Center

A research study for patients who are being treated for atrial fibrillation

Bismarck : 1160.129.32365 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Fargo : Lillestol Research LLC

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Fargo :

A Phase 3 clinical study for patients with Cardiovascular Disease

Fargo : Lillestol Research LLC

A Phase 3 clinical study for patients with Cardiovascular Disease

Minot : 1160.129.32220 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Ohio

Akron : Summa Health System

A clinical research study of MultiStem and Placebo for the treatment of Ischemic Stroke

Akron :

A Phase 3 clinical study for patients with Cardiovascular Disease

Canton :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Centerville :

A Phase 3 clinical study for patients with Cardiovascular Disease

Cincinnati : University of Cincinnati

A clinical research study of MultiStem and Placebo for the treatment of Ischemic Stroke

Cincinnati : University of Cincinnati

A clinical research study of NBS-guided rTMS and Sham rTMS for the treatment of Stroke

Cincinnati : Medpace Clinical Pharmacology Unit

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Cincinnati : Sterling Research Group, Ltd.

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Cincinnati : Metabolic and Atherosclerosis Research Center

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Cincinnati : The Lindner Center for Research and Education at The Christ Hospital

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Cincinnati :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Cincinnati :

A clinical trial seeking patients for a research study for the treatment of Sialorrhea

Cincinnati :

A Phase 3 clinical study for patients with Cardiovascular Disease

Cincinnati : Sterling Research Group, Ltd.

A Phase 3 clinical study for patients with Cardiovascular Disease

Cincinnati : Metabolic and Atherosclerosis Research Center

A Phase 3 clinical study for patients with Cardiovascular Disease

Cincinnati : Medpace Clinical Pharmacology Unit

A Phase 3 clinical study for patients with Cardiovascular Disease

Cincinnati : The Lindner Center for Research and Education at The Christ Hospital

A Phase 3 clinical study for patients with Cardiovascular Disease

Cincinnati : Stroke Center

Patients are needed to participate in a clinical research study evaluating 3K3A-APC and Placebo for the treatment of Ischemic Stroke

Cleveland : Case Western Reserve University School of Medicine

A clinical research study of MultiStem and Placebo for the treatment of Ischemic Stroke

Cleveland : MetroHealth Medical Center

A clinical research study of MultiStem and Placebo for the treatment of Ischemic Stroke

Cleveland : Cleveland Clinic

A clinical research study of MultiStem and Placebo for the treatment of Ischemic Stroke

Cleveland : 1160.129.32273 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Cleveland : University Hospitals of Cleveland

A clinical trial seeking patients for a research study for the treatment of Stroke, Brain Ischemia, Vasospasm, Intracranial or Hemorrhage, Intracranial

Cleveland : Cleveland Clinic

A clinical trial to evaluate treatments using RP-1127 (Glyburide for Injection) for patients with Ischemic Stroke or Malignant Edema

Columbus : The Ohio State University

A clinical study for patients with Cryptogenic Stroke

Columbus : Ohio State University

A clinical research study of NBS-guided rTMS and Sham rTMS for the treatment of Stroke

Columbus : Riverside Methodist Hospital/ Ohio Health Research Institute

A clinical trial seeking patients for an Ischemic Stroke treatment research study

Columbus : Riverside Hospital

A clinical trial to evaluate treatments using Flow Detection System for patients with Right to Left Shunt, Patent Foramen Ovale or Atrial Septal Defect

Columbus : Ohio State University Wexner Medical Center

A clinical trial to evaluate treatments using RP-1127 (Glyburide for Injection) for patients with Ischemic Stroke or Malignant Edema

Columbus :

A Phase 3 clinical study for patients with Cardiovascular Disease

Columbus : Stroke Center

Patients are needed to participate in a clinical research study evaluating 3K3A-APC and Placebo for the treatment of Ischemic Stroke

Dayton :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Dayton :

A Phase 3 clinical study for patients with Cardiovascular Disease

Delaware :

A Phase 3 clinical study for patients with Cardiovascular Disease

Fairfield :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Fairview Park : 1160.129.32061 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Franklin :

A Phase 3 clinical study for patients with Cardiovascular Disease

Hudson : 1160.129.32060 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Kettering :

A Phase 3 clinical study for patients with Cardiovascular Disease

Lyndhurst :

A Phase 3 clinical study for patients with Cardiovascular Disease

Marion : SV Research, LLC

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Marion : 1160.129.32316 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Marion : 1160.129.32158 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Marion :

A Phase 3 clinical study for patients with Cardiovascular Disease

Marion : SV Research LLC

A Phase 3 clinical study for patients with Cardiovascular Disease

Mentor :

A Phase 3 clinical study for patients with Cardiovascular Disease

Miamisburg : 1160.129.32012 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Middleburg Heights :

A Phase 3 clinical study for patients with Cardiovascular Disease

Perrysburg : Daniel G. Williams, MD

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Perrysburg : Office of Daniel G. Williams, MD

A Phase 3 clinical study for patients with Cardiovascular Disease

Perrysburg :

A Phase 3 clinical study for patients with Cardiovascular Disease

Sandusky : North Ohio Heart Center, Inc.

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Sandusky : North Ohio Heart Center, Inc.

A Phase 3 clinical study for patients with Cardiovascular Disease

Sandusky :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Springfield : 1160.129.32244 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Toledo : 1160.129.32285 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Toledo : 1160.129.32349 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Toledo :

A Phase 3 clinical study for patients with Cardiovascular Disease

Toledo :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Valley View : Great Lakes NeuroTechnologies

A clinical trial seeking patients for a research study for the treatment of Stroke, Dystonia or Cerebral Palsy

Willoughby :

A Phase 3 clinical study for patients with Cardiovascular Disease

Willoughby Hills :

A Phase 3 clinical study for patients with Cardiovascular Disease

Oklahoma

Norman : LION Research

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Norman : LION Research

A Phase 3 clinical study for patients with Cardiovascular Disease

Oklahoma City : Oklahoma Heart Hospital Research Foundation

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Oklahoma City : Oklahoma Heart Hospital Physicians

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Oklahoma City : Oklahoma Heart Hospital

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Oklahoma City : 1160.129.32258 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Oklahoma City : 1160.129.32425 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Oklahoma City :

A Phase 3 clinical study for patients with Cardiovascular Disease

Tulsa :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Tulsa :

A clinical trial seeking patients for a research study for the treatment of Sialorrhea

Tulsa :

A Phase 3 clinical study for patients with Cardiovascular Disease

Oregon

Ashland :

A Phase 3 clinical study for patients with Cardiovascular Disease

Bend :

A Phase 3 clinical study for patients with Cardiovascular Disease

Corvallis : 1160.129.32374 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Eugene :

A Phase 3 clinical study for patients with Cardiovascular Disease

Hillsboro : Hillsboro Cardiology, P.C.

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Hillsboro : Hillsboro Cardiology, P.C.

A Phase 3 clinical study for patients with Cardiovascular Disease

Portland : Oregon Health Sciences University

A clinical research study of MultiStem and Placebo for the treatment of Ischemic Stroke

Portland : 1160.129.32163 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Portland : Oregon Health and Science University

A clinical trial seeking patients for a research study for the treatment of Stroke, Cerebrovascular Accident or Hemiparesis

Portland : Oregon Health & Science University Hospital

A clinical trial to evaluate treatments using RP-1127 (Glyburide for Injection) for patients with Ischemic Stroke or Malignant Edema

Portland :

A Phase 3 clinical study for patients with Cardiovascular Disease

Springfield : 1160.129.32366 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Pennsylvania

Abington :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Abington : 1160.129.32400 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Abington : Abington Memorial Hospital

A clinical trial to evaluate treatments using RP-1127 (Glyburide for Injection) for patients with Ischemic Stroke or Malignant Edema

Altoona :

A Phase 3 clinical study for patients with Cardiovascular Disease

Bensalem :

A Phase 3 clinical study for patients with Cardiovascular Disease

Bethlehem :

A Phase 3 clinical study for patients with Cardiovascular Disease

Camp Hill : 1160.129.32236 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Carnegie : 1160.129.32086 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Chambersburg : 1160.129.32206 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Clairton : Jefferson Cardiology Association

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Clairton : Jefferson Cardiology Association

A Phase 3 clinical study for patients with Cardiovascular Disease

Downingtown : Brandywine Clinical Research

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Downingtown :

A Phase 3 clinical study for patients with Cardiovascular Disease

Downingtown : Brandywine Clinical Research

A Phase 3 clinical study for patients with Cardiovascular Disease

Doylestown : Doylestown Cardiology Associates - VIAA

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Doylestown : 1160.129.32157 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Doylestown : Doylestown Cardiology Associates - VIAA

A Phase 3 clinical study for patients with Cardiovascular Disease

Doylestown :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Duncansville :

A Phase 3 clinical study for patients with Cardiovascular Disease

Ephrata : 1160.129.32398 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Ephrata :

A Phase 3 clinical study for patients with Cardiovascular Disease

Feasterville :

A Phase 3 clinical study for patients with Cardiovascular Disease

Harleysville : 1160.129.32113 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Hershey : The Pennsylvania State University

A clinical research study of MultiStem and Placebo for the treatment of Ischemic Stroke

Jersey Shore : 1160.129.32127 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Langhorne :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Lansdale : Green and Seidner Family Practice Associates

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Lansdale : 1160.129.32153 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Lansdale :

A Phase 3 clinical study for patients with Cardiovascular Disease

Lansdale : Green and Seidner Family Practice Associates

A Phase 3 clinical study for patients with Cardiovascular Disease

Levittown : Family Medical Associates

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Levittown : Family Medical Associates

A Phase 3 clinical study for patients with Cardiovascular Disease

Philadelphia : Hospital for the University of Pennsylvania

A clinical research study of MultiStem and Placebo for the treatment of Ischemic Stroke

Philadelphia : Philadelphia Health Associates-Adult Medicine

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Philadelphia :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Philadelphia : 1160.129.32323 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Philadelphia : 1160.129.32371 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Philadelphia : 1160.129.32337 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Philadelphia :

A clinical trial to evaluate treatments using Rivaroxaban (Xarelto, BAY59-7939), Aspirin (Acetylsalicylic acid, BAY1019036), Rivaroxaban-Placebo and Aspirin-Placebo for patients with Stroke

Philadelphia :

A Phase 3 clinical study for patients with Cardiovascular Disease

Pittsburgh : University of Pittsburgh Medical Center Health System

A clinical research study of MultiStem and Placebo for the treatment of Ischemic Stroke

Pittsburgh : Allegheny Endocrinology Associates

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Pittsburgh : Preferred Primary Care Physicians

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Pittsburgh : 1160.129.32406 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Pittsburgh : UPMC Stroke Institute

A clinical trial seeking patients for an Ischemic Stroke treatment research study

Pittsburgh : UPMC Presbyterian Hospital

A clinical trial to evaluate treatments using RP-1127 (Glyburide for Injection) for patients with Ischemic Stroke or Malignant Edema

Pittsburgh : Allegheny Endocrinology Associates

A Phase 3 clinical study for patients with Cardiovascular Disease

Pittsburgh :

A Phase 3 clinical study for patients with Cardiovascular Disease

Pittsburgh : Preferred Primary Care Physicians

A Phase 3 clinical study for patients with Cardiovascular Disease

Pittsburgh : Stroke Center

Patients are needed to participate in a clinical research study evaluating 3K3A-APC and Placebo for the treatment of Ischemic Stroke

Quakertown :

A Phase 3 clinical study for patients with Cardiovascular Disease

Sayre : Guthrie Medical Group, PC

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Sayre :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Sayre : Guthrie Medical Group, PC

A Phase 3 clinical study for patients with Cardiovascular Disease

Sellersville : 1160.129.32192 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Upper St. Clair :

A Phase 3 clinical study for patients with Cardiovascular Disease

Warminster : 1160.129.32109 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Willow Grove : 1160.189.10205 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Wynnewood :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Wyomissing :

A Phase 3 clinical study for patients with Cardiovascular Disease

Yardley : 1160.129.32137 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Yardley :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

York :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Rhode Island

Cranston :

A Phase 3 clinical study for patients with Cardiovascular Disease

Cumberland :

A Phase 3 clinical study for patients with Cardiovascular Disease

East Providence :

A Phase 3 clinical study for patients with Cardiovascular Disease

Pawtucket : 1160.129.32224 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Wakefield : 1160.129.32384 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

South Carolina

Mt. Pleasant : PMG Research of Charleston

Have you suffered from a heart attack or stroke?

Anderson : 1160.129.32243 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Anderson : 1160.129.32160 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Anderson :

A Phase 3 clinical study for patients with Cardiovascular Disease

Charleston : Coastal Cardiology

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Charleston : Coastal Cardiology

A Phase 3 clinical study for patients with Cardiovascular Disease

Charleston :

A Phase 3 clinical study for patients with Cardiovascular Disease

Columbia : Palmetto Health Richland

A clinical research study of MultiStem and Placebo for the treatment of Ischemic Stroke

Columbia : 1160.129.32050 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Columbia :

A Phase 3 clinical study for patients with Cardiovascular Disease

Greenville : Upstate Pharmaceutical Research

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Greenville :

A Phase 3 clinical study for patients with Cardiovascular Disease

Greenville : Upstate Pharmaceutical Research

A Phase 3 clinical study for patients with Cardiovascular Disease

Greenwood : 1160.129.32424 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Greenwood :

A Phase 3 clinical study for patients with Cardiovascular Disease

Greer :

A Phase 3 clinical study for patients with Cardiovascular Disease

Hodges :

A Phase 3 clinical study for patients with Cardiovascular Disease

Murrells Inlet : The Diabetes Center

A Phase 3 clinical study for patients with Cardiovascular Disease

Murrells Inlet :

A Phase 3 clinical study for patients with Cardiovascular Disease

Myrtle Beach : 1160.129.32108 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Myrtle Beach :

A Phase 3 clinical study for patients with Cardiovascular Disease

Orangeburg :

A Phase 3 clinical study for patients with Cardiovascular Disease

Pelzer :

A Phase 3 clinical study for patients with Cardiovascular Disease

Port Royal : Acorda Investigational Site Updated

A clinical trial seeking patients for a research study for the treatment of Post-Ischemic Stroke

Port Royal :

A clinical trial seeking patients for a research study for the treatment of Sialorrhea

Rock Hill :

A Phase 3 clinical study for patients with Cardiovascular Disease

Simpsonville :

A Phase 3 clinical study for patients with Cardiovascular Disease

Spartanburg :

A Phase 3 clinical study for patients with Cardiovascular Disease

South Dakota

Rapid City : 1160.129.32267 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Sioux Falls :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Sioux Falls :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Tennessee

Bristol : PMG Research of Bristol

Heart Attack...Stroke. Are you at risk?

Athens :

A Phase 3 clinical study for patients with Cardiovascular Disease

Chattanooga : Chattanooga Center for Neurologic Research

A clinical research study of MultiStem and Placebo for the treatment of Ischemic Stroke

Chattanooga : 1160.129.32217 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Chattanooga : Erlanger Health care system

A Phase 2 clinical study for patients with Stroke

Chattanooga :

A Phase 3 clinical study for patients with Cardiovascular Disease

Clarksville :

A Phase 3 clinical study for patients with Cardiovascular Disease

Collierville :

A Phase 3 clinical study for patients with Cardiovascular Disease

Cordova :

A clinical trial seeking patients for a research study for the treatment of Sialorrhea

Fayetteville :

A Phase 3 clinical study for patients with Cardiovascular Disease

Jackson : 1160.129.32338 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Jackson :

A Phase 3 clinical study for patients with Cardiovascular Disease

Johnson City : 1160.129.32272 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Kingsport :

A Phase 3 clinical study for patients with Cardiovascular Disease

Knoxville : Volunteer Research Group

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Knoxville : New Orleans Center for Clinical Research

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Knoxville : 1160.129.32287 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Knoxville : 1160.129.32080 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Knoxville : 1160.129.32082 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Knoxville : New Orleans Center for Clinical Research

A Phase 3 clinical study for patients with Cardiovascular Disease

Knoxville : Volunteer Research Group

A Phase 3 clinical study for patients with Cardiovascular Disease

Memphis :

A Phase 3 clinical study for patients with Cardiovascular Disease

Nashville : Stroke Center

Patients are needed to participate in a clinical research study evaluating 3K3A-APC and Placebo for the treatment of Ischemic Stroke

Nashville : Vanderbilt Univiersity

Patients are needed to participate in a clinical research study evaluating Detrol LA for the treatment of Urinary Incontinence or Bladder Dysfunction

Nashville : Vanderbilt University Medical Center

Patients are needed to participate in a clinical research study evaluating Penumbra System with Separator 3D and Penumbra System alone for the treatment of Acute Ischemic Stroke From Large Vessel Occlusion

New Tazewell :

A Phase 3 clinical study for patients with Cardiovascular Disease

Texas

Dallas : Children’s Medical Center of Dallas Updated

BOTOX® Treatment in Pediatric Lower Limb Spasticity

Dallas : Children’s Medical Center of Dallas Updated

BOTOX® Treatment in Pediatric Upper Limb Spasticity

San Antonio : Road Runner Research Updated

BOTOX® Treatment in Pediatric Lower Limb Spasticity

San Antonio : Road Runner Research Updated

BOTOX® Treatment in Pediatric Upper Limb Spasticity

Allen :

A Phase 3 clinical study for patients with Cardiovascular Disease

Arlington : Arlington Family Research Center, Inc.

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Arlington : Arlington Family Research Center, Inc.

A Phase 3 clinical study for patients with Cardiovascular Disease

Austin : 1160.129.32145 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Beaumont : 1160.129.32095 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Bellaire :

A Phase 3 clinical study for patients with Cardiovascular Disease

Carrollton :

A Phase 3 clinical study for patients with Cardiovascular Disease

Dallas : VA North Texas Health Care System - Dallas VAMC

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Dallas : Research Institute of Dallas

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Dallas : Dallas Diabetes and Endocrine Center

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Dallas : UT Southwestern

A clinical research study of Vagus Nerve Stimulation (VNS) for the treatment of Stroke or Upper Limb Deficits

Dallas : Acorda Investigational Site Updated

A clinical trial seeking patients for a research study for the treatment of Post-Ischemic Stroke

Dallas : 1160.129.32322 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Dallas : 1160.129.32252 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Dallas :

A Phase 3 clinical study for patients with Cardiovascular Disease

Dallas : VA North Texas Health Care System - Dallas VAMC

A Phase 3 clinical study for patients with Cardiovascular Disease

Dallas : Research Institute of Dallas

A Phase 3 clinical study for patients with Cardiovascular Disease

DeSoto :

A Phase 3 clinical study for patients with Cardiovascular Disease

El Paso :

A Phase 3 clinical study for patients with Cardiovascular Disease

Fort Worth : T & R Clinic, PA

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Fort Worth :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Fort Worth : 1160.129.32300 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Fort Worth :

A Phase 3 clinical study for patients with Cardiovascular Disease

Grapevine :

A Phase 3 clinical study for patients with Cardiovascular Disease

Houston : The University of Texas Health Science Center

A clinical research study of MultiStem and Placebo for the treatment of Ischemic Stroke

Houston : Methodist Hospital Research Institute

A clinical research study of MultiStem and Placebo for the treatment of Ischemic Stroke

Houston : TIRR Memorial Hermann Hospital

A clinical research study of NBS-guided rTMS and Sham rTMS for the treatment of Stroke

Houston : DM Clinical Research

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Houston : Baylor College of Medicine

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Houston : Texas Center for Drug Development, P.A

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Houston : Centex Studies, Inc.

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Houston : UT Houston

A clinical research study of Vagus Nerve Stimulation (VNS) for the treatment of Stroke or Upper Limb Deficits

Houston :

A clinical trial seeking patients for a research study for the treatment of Sialorrhea

Houston : 1160.129.32295 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Houston : 1160.129.32301 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Houston : 1160.129.32100 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Houston : 1160.129.32092 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Houston : Methodist DeBakey Heart and Vascular Center

A clinical trial to evaluate treatments using Flow Detection System for patients with Right to Left Shunt, Patent Foramen Ovale or Atrial Septal Defect

Houston : Texas Center For Drug Development, Inc.

A Phase 3 clinical study for patients with Cardiovascular Disease

Houston : Baylor College of Medicine

A Phase 3 clinical study for patients with Cardiovascular Disease

Houston :

A Phase 3 clinical study for patients with Cardiovascular Disease

Houston : Northwest Houston Cardiology

A Phase 3 clinical study for patients with Cardiovascular Disease

Houston : DM Clinical Research

A Phase 3 clinical study for patients with Cardiovascular Disease

Houston : Centex Studies, Inc.

A Phase 3 clinical study for patients with Cardiovascular Disease

Houston : Baylor College of Medicine

Patients are needed to participate in a clinical research study for the treatment of Atherosclerotic Disease, Carotid

Humble : 1160.129.32219 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Irving :

A Phase 3 clinical study for patients with Cardiovascular Disease

Katy : 1160.129.32171 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Kingwood :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Kingwood : 1160.129.32211 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Kingwood : 1160.189.11221 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Mckinney :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Nassau Bay :

A Phase 3 clinical study for patients with Cardiovascular Disease

New Braunfels : Hill Country Medical Associates

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

New Braunfels : 1160.129.32189 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

New Braunfels :

A Phase 3 clinical study for patients with Cardiovascular Disease

New Braunfels : Hill Country Medical Associates

A Phase 3 clinical study for patients with Cardiovascular Disease

Odessa :

A Phase 3 clinical study for patients with Cardiovascular Disease

Pasadena : Med-Olam Clinical Research, LLC.

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Pasadena : Med-Olam Clinical Research

A Phase 3 clinical study for patients with Cardiovascular Disease

Plano :

A Phase 3 clinical study for patients with Cardiovascular Disease

Richardson :

A Phase 3 clinical study for patients with Cardiovascular Disease

San Antonio : Bandera Family Health Care

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

San Antonio :

A clinical trial seeking patients for a research study for the treatment of Sialorrhea

San Antonio : 1160.129.32187 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

San Antonio :

A Phase 3 clinical study for patients with Cardiovascular Disease

San Antonio : BFHC Research

A Phase 3 clinical study for patients with Cardiovascular Disease

San Antonio : Bandera Family Health Care

A Phase 3 clinical study for patients with Cardiovascular Disease

San Antonio :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Sealy : 1160.129.32288 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Seguin : 1160.129.32191 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Southlake :

A Phase 3 clinical study for patients with Cardiovascular Disease

Sugar Land : 1160.129.32068 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Sugar Land :

A Phase 3 clinical study for patients with Cardiovascular Disease

Tomball : Northwest Heart Center

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Tomball : Northwest Heart Center

A Phase 3 clinical study for patients with Cardiovascular Disease

Tomball :

A Phase 3 clinical study for patients with Cardiovascular Disease

Tyler : 1160.129.32345 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Tyler : 1160.129.32306 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Tyler : 1160.129.32418 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Waco : 1160.129.32334 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Waco :

A Phase 3 clinical study for patients with Cardiovascular Disease

Utah

Bountiful :

A Phase 3 clinical study for patients with Cardiovascular Disease

Draper :

A Phase 3 clinical study for patients with Cardiovascular Disease

Salt Lake City : University of Utah

A clinical research study of MultiStem and Placebo for the treatment of Ischemic Stroke

Salt Lake City : Heart Center at St. Mark's Hospital

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Salt Lake City : Optimum Clinical Research, Inc

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Salt Lake City :

A clinical trial seeking patients for a research study for the treatment of Sialorrhea

Salt Lake City : 1160.129.32121 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Salt Lake City : University of Utah Healthcare

A clinical trial to evaluate treatments using RP-1127 (Glyburide for Injection) for patients with Ischemic Stroke or Malignant Edema

Salt Lake City :

A Phase 3 clinical study for patients with Cardiovascular Disease

Salt Lake City : Optimum Clinical Research, Inc.

A Phase 3 clinical study for patients with Cardiovascular Disease

Salt Lake City : Stroke Center

Patients are needed to participate in a clinical research study evaluating 3K3A-APC and Placebo for the treatment of Ischemic Stroke

Salt Lake City : Western Institute for Biomedical Research

Patients are needed to participate in a clinical research study for the treatment of Atherosclerotic Disease, Carotid

West Jordan :

A Phase 3 clinical study for patients with Cardiovascular Disease

Vermont

Burlington :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Virginia

Alexandria :

A Phase 3 clinical study for patients with Cardiovascular Disease

Arlington :

A Phase 3 clinical study for patients with Cardiovascular Disease

Burke : Clinical Research Institute of Northern Virginia

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Burke : Burke Internal Medicine & Research

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Burke : 1160.129.32166 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Burke : Burke Internal Medicine & Research

A Phase 3 clinical study for patients with Cardiovascular Disease

Burke :

A Phase 3 clinical study for patients with Cardiovascular Disease

Charlottesville : 1160.129.32377 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Chesapeake : 1160.129.32004 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Danville :

A Phase 3 clinical study for patients with Cardiovascular Disease

Falls Church : 1160.129.32146 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Harrisonburg : James Madison University and Rockingham Memorial Hospital

A clinical research study of Passy Muir Swallowing Self-Trainer for the treatment of Dysphagia or Stroke

Harrisonburg : 1160.129.32363 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Manassas : 1160.129.32200 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Manassas : 1160.129.32328 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Manassas :

A Phase 3 clinical study for patients with Cardiovascular Disease

Midlothian : 1160.129.32279 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Norfolk :

A Phase 3 clinical study for patients with Cardiovascular Disease

Richmond : 1160.129.32403 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Richmond :

A Phase 3 clinical study for patients with Cardiovascular Disease

Roanoke : 1160.129.32357 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Salem : 1160.129.32367 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Salem :

A Phase 3 clinical study for patients with Cardiovascular Disease

Suffolk : Hampton Roads Center for Clinical Research

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Suffolk : Hampton Roads Center for Clinical Research

A Phase 3 clinical study for patients with Cardiovascular Disease

Virginia Beach :

A Phase 3 clinical study for patients with Cardiovascular Disease

Winchester : 1160.129.32369 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Washington

Bellevue : 1160.189.10237 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Burien : The Office of Daniel W. Gottlieb, MD, PS

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Burien : Office of Daniel W. Gottlieb, MD, PS

A Phase 3 clinical study for patients with Cardiovascular Disease

Kirkland :

A clinical trial seeking patients for a research study for the treatment of Sialorrhea

Port Orchard : 1160.129.32227 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Port Orchard :

A Phase 3 clinical study for patients with Cardiovascular Disease

Puyallup :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Puyallup :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Seattle : 1160.129.32241 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Seattle : Swedish Medical Center

A clinical trial to evaluate treatments using Flow Detection System for patients with Right to Left Shunt, Patent Foramen Ovale or Atrial Septal Defect

Seattle :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Spokane :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Tacoma :

A clinical trial seeking patients for a research study for the treatment of Sialorrhea

Tacoma : 1160.129.32373 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Tacoma :

A Phase 3 clinical study for patients with Cardiovascular Disease

Wenatchee : Wenatchee Valley Hospital & Clinics

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Wenatchee : Wenatchee Valley Medical Center

A Phase 3 clinical study for patients with Cardiovascular Disease

Wenatchee : Wenatchee Valley Hospital and Clinics

A Phase 3 clinical study for patients with Cardiovascular Disease

West Virginia

Charleston : 1160.129.32385 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Clarksburg :

A Phase 3 clinical study for patients with Cardiovascular Disease

Fairmont : Exemplar Research Inc

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Fairmont : Exemplar Research Inc

A Phase 3 clinical study for patients with Cardiovascular Disease

Huntington : 1160.129.32359 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Morgantown : West Virginia University

Patients are needed to participate in a clinical research study for the treatment of Atherosclerotic Disease, Carotid

Wisconsin

Marshfield : Marshfield Clinic Updated

BOTOX® Treatment in Pediatric Lower Limb Spasticity

Marshfield : Marshfield Clinic Updated

BOTOX® Treatment in Pediatric Upper Limb Spasticity

Green Bay :

A Phase 3 clinical study for patients with Cardiovascular Disease

La Crosse : 1160.129.32308 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Milwaukee :

A Phase 3 clinical study for patients with Cardiovascular Disease

Oregon :

A Phase 3 clinical study for patients with Cardiovascular Disease

Waukesha : 1160.129.32355 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Wauwatosa :

A Phase 3 clinical study for patients with Cardiovascular Disease

Weston :

A Phase 3 clinical study for patients with Cardiovascular Disease

Argentina

Adrogue :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Bahia Blanca : Instituto de Investigaciones Clinicas Bahia Blanca

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Bahia Blanca : Hospital Italiano Regional del Sur

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Bahia Blanca :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Bahía Blanca :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Buenos Aires :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Buenos Aires : 1160.129.21012 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Buenos Aires : 1160.129.21009 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Buenos Aires : 1160.129.21008 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Buenos Aires :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Buenos Aires :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

C.a.b.a. : CIPREC - Centro de Investigacion y Prevencion Cardiovascular S.A.

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Ciudad Autonoma Buenos Aires :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Ciudad Autonoma De Buenos Aires :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Cordoba :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Córdoba :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Córdoba :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Córdoba :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Cordoba Capital :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Coronel Suarez :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Corrientes : Instituto de Cardiologia de Corrientes "Juana Fca. Cabral"

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Corrientes : 1160.129.21006 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Corrientes : Instituto de Cardiologia de Corrientes "Juana Fca. Cabral"

A Phase 3 clinical study for patients with Cardiovascular Disease

Corrientes :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Esperanza :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Godoy Cruz : 1160.129.21010 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Junín :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

La Plata :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

La Plata :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

La Plata :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Many Locations : Updated

A clinical trial seeking patients for a research study for the treatment of Atrial Fibrillation

Mar Del Plata : Instituto de Investigaciones Clinicas (IIC) - Mar del Plata

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Mar Del Plata :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Mar Del Plata : Instituto de Investigaciones Clinicas (IIC) - Mar del Plata

A Phase 3 clinical study for patients with Cardiovascular Disease

Mar del Plata :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Merlo :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Munro :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Quilmes :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Rafaela :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Ramos Mejía :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Rosario :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Rosario :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Salta :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

San Juan :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

San luis :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

San Martín :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

San Miguel de Tucumán :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

San Nicolás :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Santa Fe :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Santa Fe :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Santa Rosa :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Tucuman :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Tucumán : 1160.129.21013 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Tucumán : Dr Hector Luciardi, National Co-ordinating Investigator, National University of Tucuman

Patients are needed to participate in a clinical research study for the treatment of Atrial Fibrillation

Venado Tuerto :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Vicente Lopez :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Villa Allende :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Villa María :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Zárate :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Zarate, Buenos Aires :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Australia

Adelaide : 1160.189.61205 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Bedford Park : 1160.189.61207 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Box Hill : 1160.189.61202 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Chermside : Holy Spirit Northside Private Hospital Limited

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Chermside : Holy Spirit Northside Private Hospital Limited

A Phase 3 clinical study for patients with Cardiovascular Disease

Darlinghurst : 1160.189.61208 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Geelong : Barwon Health-University Hospital,Geelong

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Geelong : Barwon Health-The Geelong Hospital

A Phase 3 clinical study for patients with Cardiovascular Disease

Gosford : Central Coast Local Health District, Gosford Hospital

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Herston : Royal Brisbane and Women's Hospital

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Herston : Royal Brisbane and Women's Hospital

A Phase 3 clinical study for patients with Cardiovascular Disease

Herston : 1160.189.61203 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Joondalup : HPS Pharmacies

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Joondalup : Joondalup Cardiovascular Trials Foundation Inc.

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Joondalup : Joondalup Cardiovascular Trials Foundation Inc.

A Phase 3 clinical study for patients with Cardiovascular Disease

Joondalup : HPS Pharmacies

A Phase 3 clinical study for patients with Cardiovascular Disease

Kanwal : 1160.189.61210 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Launceston : Launceston General Hospital

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Melbourne : Harry Gibbs, National Co-ordinating Investigator, The Alfred Hospital

Patients are needed to participate in a clinical research study for the treatment of Atrial Fibrillation

Milton : Core Research Group Pty Ltd

A Phase 3 clinical study for patients with Cardiovascular Disease

New Lambton : 1160.189.61209 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Parkville : 1160.189.61204 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Redcliffe : Redcliffe Hospital

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

St Leonards : 1160.189.61206 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Sydney : Royal Prince Alfred Hospital

A clinical trial seeking patients for a research study for the treatment of Vascular Death, Myocardial Infarction, Stroke or Cardiac Surgery

Austria

Bad Pirawarth : 1160.136.34007 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Graz : Universitätsklinikum für Neurologie

A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident

Graz : Marianne Brodmann: National Co-ordinating Investigator, Medizinische Universität Graz

Patients are needed to participate in a clinical research study for the treatment of Atrial Fibrillation

Innsbruck : 1160.189.43205 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Linz : 1160.136.34011 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Linz : 1160.136.34001 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Oberwart : 1160.136.34008 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Wien : 1160.136.34004 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Azerbaijan

Many Locations : Updated

A clinical trial seeking patients for a research study for the treatment of Atrial Fibrillation

Bahrain

Many Locations : Updated

A clinical trial seeking patients for a research study for the treatment of Atrial Fibrillation

Belgium

Aalst : OLV Ziekenhuis

A clinical trial to evaluate treatments for patients with Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke (WATCHMAN)

Bouge/Namur : 1160.136.58008 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Brasschaat : Dr Frank Cools, National Co-ordinating Investigator, AZ Klina

Patients are needed to participate in a clinical research study for the treatment of Atrial Fibrillation

Brugge : AZ Sint-Jan Brugge

A Phase 3 clinical study for patients with Cardiovascular Disease

Brugge : 1160.136.58005 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Brussel : 1160.136.58007 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Brussel : 1160.136.58001 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Brussel : 1160.189.32210 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Brussel : 1160.189.32209 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Brussels : University Hospital Brussels - Centrum voor hart- en vaatziekten

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Brussels : University Hospital Brussels- Diabeteskliniek

A Phase 3 clinical study for patients with Cardiovascular Disease

Brussels : University Hospital Brussels - Centrum voor hart- en vaatziekten

A Phase 3 clinical study for patients with Cardiovascular Disease

Bruxelles : 1160.136.58004 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Bruxelles : 1160.189.32202 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Different : 11 Sites

A clinical research study of early standardised rhythm control for the treatment of Atrial Fibrillation or Stroke

Genk : ZOL Campus Sint-Jan

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Genk : ZOL Campus Sint-Jan

A Phase 3 clinical study for patients with Cardiovascular Disease

Genk : 1160.136.58009 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Gent : 1160.189.32203 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Huy : Centre Hospitalier Regional de Huy

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Huy : Centre Hospitalier Regional de Huy

A Phase 3 clinical study for patients with Cardiovascular Disease

Kortrijk : 1160.189.32207 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Leuven : University Hospitals Leuven - Neurology department

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Leuven : University Hospitals Leuven - Neurology department

A Phase 3 clinical study for patients with Cardiovascular Disease

Leuven :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Leuven : 1160.189.32201 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Liège : 1160.136.58002 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Liège : 1160.189.32204 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Ottignies : 1160.136.58003 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Roeselare : 1160.189.32211 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Tienen : Dr. Luc De Wolf - Private Practice

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Tienen : Dr. Luc De Wolf - Private Practice

A Phase 3 clinical study for patients with Cardiovascular Disease

Tienen : 1160.136.58006 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Wilrijk : 1160.189.32208 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Yvoir : 1160.189.32206 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Brazil

Belem : 1160.129.22015 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Belo Horizonte : 1160.129.22012 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Belo Horizonte : 1160.129.22011 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Belo Horizonte :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Blumenau : 1160.129.22029 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Blumenau :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Brasilia : 1160.129.22004 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Campina Grande do Sul :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Campinas : 1160.129.22017 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Campinas :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Campinas :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Campinas :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Curitiba : 1160.129.22016 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Curitiba :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Goiania :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Maceio : 1160.129.22024 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Passo Fundo : 1160.129.22021 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Pelotas :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Porto Alegre : 1160.129.22026 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Porto Alegre : 1160.129.22028 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Porto Alegre : 1160.129.22005 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Porto Alegre :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Salvador : 1160.129.22002 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Salvador : 1160.129.22023 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Sao Jose do Rio Preto : 1160.129.22001 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

São José do Rio Preto :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

São José do Rio Preto :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Sao Paolo : Dr Antonio Barretto, National Coordinating Investigator, Hospital Santa Marcelina,

Patients are needed to participate in a clinical research study for the treatment of Atrial Fibrillation

Sao Paulo : 1160.129.22018 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Sao Paulo : 1160.129.22009 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Sao Paulo : 1160.129.22008 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Sao Paulo : 1160.129.22003 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Tatui : 1160.129.22032 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Uberlândia :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Votuporanga : 1160.129.22025 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Votuporanga :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Bulgaria

Blagoevgrad :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Burgas :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Burgas : 1160.136.36004 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Kazanlak :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Kazanlak : 1160.136.36002 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Pazardzhik :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Pleven :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Plovdiv :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Plovdiv : 1160.136.36008 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Rousse :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Rousse : 1160.136.36005 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Sevlievo : 1160.136.36001 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Sliven : 1160.136.36013 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Sofia :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Sofia : 1160.136.36007 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Sofia : 1160.136.36003 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Sofia : 1160.136.36012 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Sofia : 1160.136.36011 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Sofia : 1160.136.36014 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Stara Zagora : 1160.136.36009 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Varna :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Varna : 1160.136.36015 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Veliko Tarnovo :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Yambol : 1160.136.36006 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Canada

Brampton : LMC Diabetes & Endocrinology (Brampton)

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Brampton : CCRN

A clinical trial seeking patients for a research study for the treatment of Cardiovascular Diseases

Brampton :

A Phase 3 clinical study for patients with Cardiovascular Disease

Brampton : LMC Diabetes & Endocrinology (Brampton)

A Phase 3 clinical study for patients with Cardiovascular Disease

Brampton :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Brampton, ON :

A Phase 3 clinical study for patients with Cardiovascular Disease

Burlington :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Burlington :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Calgary : 1160.129.06018 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Calgary :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Calgary : 1160.189.15210 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Cambridge : 1160.129.06023 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Cambridge : Vizel Cardiac Research - Saul Vizel Professional Medicine Corporation

A Phase 3 clinical study for patients with Cardiovascular Disease

Cambridge :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Cambridge :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Chicoutimi : Q & T Research Chicoutimi

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Chicoutimi : Q&T Research Chicoutimi

A Phase 3 clinical study for patients with Cardiovascular Disease

Chicoutimi :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Edmonton :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Edmonton : 1160.129.06004 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Edmonton :

A Phase 3 clinical study for patients with Cardiovascular Disease

Edmonton : University of Alberta

Patients are needed to participate in a clinical research study for the treatment of Acute Ischemic Stroke or Transient Ischemic Attack

Edmonton, AB :

A Phase 3 clinical study for patients with Cardiovascular Disease

Etobicoke : Peel Regional Paramedic Services and Sunnybrook Centre for Prehospital Medicine Updated

Patients are needed to participate in a clinical research study evaluating NA-1 and Placebo for the treatment of Acute Cerebral Ischemia

Grimsby : 1160.129.06020 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Grimsby :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Halifax : QE II Health Sciences Centre

Patients are needed to participate in a clinical research study of Dalteparin and Placebo to evaluate Stroke

Halifax :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Hamilton : 1160.129.06032 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Hamilton : 1160.129.06043 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Hamilton : 1160.129.06016 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Hamilton : Hamilton Health Sciences

A clinical trial seeking patients for a research study for the treatment of Vascular Death, Myocardial Infarction, Stroke or Cardiac Surgery

Hamilton :

A Phase 3 clinical study for patients with Cardiovascular Disease

Hamilton : Prof Stuart Connolly and Dr John Eikelboom, National Coodinating Investigators, Mc Master University

Patients are needed to participate in a clinical research study for the treatment of Atrial Fibrillation

Hamilton : Hamilton Health Sciences Corporation-Henderson Site

Patients are needed to participate in a clinical research study of Dalteparin and Placebo to evaluate Stroke

Hamilton : Hamilton Health Sciences Corporation-McMaster Site

Patients are needed to participate in a clinical research study of Dalteparin and Placebo to evaluate Stroke

Hamilton : Hamilton Health Sciences Corporation-General Hospital

Patients are needed to participate in a clinical research study of Dalteparin and Placebo to evaluate Stroke

Hamilton :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Hamilton :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Hamilton, ON :

A Phase 3 clinical study for patients with Cardiovascular Disease

Kitchener :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Kitchener :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Lachenaie :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Langley, BC :

A Phase 3 clinical study for patients with Cardiovascular Disease

Laval : Centre de Recherche Clinique de Laval

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Laval :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Levis : 1160.129.06014 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Levis :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

London :

A clinical study for patients with severe Hemiparesis of the Upper Limb Following Stroke

London :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

London : 1160.129.06038 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

London :

A Phase 3 clinical study for patients with Cardiovascular Disease

London : 1160.189.15203 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

London, ON :

A Phase 3 clinical study for patients with Cardiovascular Disease

Maple Ridge :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Markham : LMC Diabetes & Endocrinology (Markham)

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Mississauga :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Moncton :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Montreal : Montreal Heart Institute

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Montreal :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Montreal :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Montreal : 1160.129.06009 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Montreal : Montreal Heart Institute

A Phase 3 clinical study for patients with Cardiovascular Disease

Montreal :

A Phase 3 clinical study for patients with Muscle Spasticity or Stroke

Montreal : Montreal General Hospital

Patients are needed to participate in a clinical research study of Dalteparin and Placebo to evaluate Stroke

Montreal : SMBD Jewish General Hospital

Patients are needed to participate in a clinical research study of Dalteparin and Placebo to evaluate Stroke

Montreal :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Montreal :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

New Westminster :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Newmarket : 1160.129.06037 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Newmarket : Newmarket Cardiology Research Group

A Phase 3 clinical study for patients with Cardiovascular Disease

Newmarket :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Newmarket :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Oakville : LMC Diabetes & Endocrinology (Oakville)

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Oakville : 1160.129.06017 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Oakville : LMC Diabetes & Endocrinology (Oakville)

A Phase 3 clinical study for patients with Cardiovascular Disease

Oakville :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Oshawa :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Oshawa :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Ottawa :

A clinical study for patients with severe Hemiparesis of the Upper Limb Following Stroke

Ottawa :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Ottawa : 1160.129.06041 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Ottawa : Ottawa Hospital-General Campus

Patients are needed to participate in a clinical research study of Dalteparin and Placebo to evaluate Stroke

Ottawa :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Peterborough :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Quebec : IUCPQ

A clinical research study of Aspirin (80 mg/d) + clopidogrel (75 mg/d) and Aspirin+Placebo for the treatment of Aortic Valve Disease, Myocardial Infarction or Stroke

Quebec :

A Phase 3 clinical study for patients with Cardiovascular Disease

Quebec :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Québec : 1160.129.06006 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Quebec, QC :

A Phase 3 clinical study for patients with Cardiovascular Disease

Saint John : 1160.129.06040 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Saint John :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Saint John's :

A Phase 3 clinical study for patients with Cardiovascular Disease

Sainte-Foy : 1160.129.06022 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Sarnia : Sarnia Institute of Clinical Research

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Sarnia, ON :

A Phase 3 clinical study for patients with Cardiovascular Disease

Scarborough :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Sherbrooke : 1160.129.06039 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Sherbrooke :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

St Johns, NF :

A Phase 3 clinical study for patients with Cardiovascular Disease

St. John's : Health Sciences Centre

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

St. John'S :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

St-Charles-Borromee : Centre de sante et de services sociaux du Nord de Lanaudiere (CSSS) - Centre hospitalier regional de

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

St-Georges, Beauce :

A Phase 3 clinical study for patients with Cardiovascular Disease

St-Jérome :

A Phase 3 clinical study for patients with Cardiovascular Disease

Stoney Creek : 1160.129.06042 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Sudbury :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Surrey : SMH Cardiology Clinical Trials Inc.

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Surrey : 1160.129.06044 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Surrey : SMH Cardiology Clinical Trials, Inc.

A Phase 3 clinical study for patients with Cardiovascular Disease

Thetford Mines :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Thornhill : LMC Diabetes & Endocrinology (Thornhill)

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Thornhill : LMC Diabetes & Endocrinology (Thornhill)

A Phase 3 clinical study for patients with Cardiovascular Disease

Thornhill :

A Phase 3 clinical study for patients with Cardiovascular Disease

Thornhill, ON :

A Phase 3 clinical study for patients with Cardiovascular Disease

Thunder Bay : Thunder Bay Regional Research Institute

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Thunder Bay : Thunder Bay Regional Research Institute

A Phase 3 clinical study for patients with Cardiovascular Disease

Toronto :

A clinical study for patients with severe Hemiparesis of the Upper Limb Following Stroke

Toronto : LMC Diabetes & Endocrinology (Bayview)

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Toronto : 1160.129.06036 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Toronto : 1160.129.06026 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Toronto : 1160.129.06031 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Toronto : 1160.129.06003 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Toronto :

A Phase 3 clinical study for patients with Cardiovascular Disease

Toronto : LMC Diabetes & Endocrinology (Bayview)

A Phase 3 clinical study for patients with Cardiovascular Disease

Toronto : Toronto Paramedic Services and Sunnybrook Centre for Prehospital Medicine Updated

Patients are needed to participate in a clinical research study evaluating NA-1 and Placebo for the treatment of Acute Cerebral Ischemia

Toronto : University Health Network - Toronto General Hospital

Patients are needed to participate in a clinical research study of Dalteparin and Placebo to evaluate Stroke

Toronto, ON :

A Phase 3 clinical study for patients with Cardiovascular Disease

Trois-Rivieres : C.I.C. Mauricie Inc.

A Phase 3 clinical study for patients with Cardiovascular Disease

Trois-Rivieres :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Vancouver : St-Paul's Hospital

A clinical research study of Aspirin (80 mg/d) + clopidogrel (75 mg/d) and Aspirin+Placebo for the treatment of Aortic Valve Disease, Myocardial Infarction or Stroke

Victoria : 1160.129.06021 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Victoria :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Windsor :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Winnipeg :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Winnipeg :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Winnipeg :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Chile

Concepción :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Many Locations : Updated

A clinical trial seeking patients for a research study for the treatment of Atrial Fibrillation

Santiago : Dr Ramon Corbalan, National Coordinating Investigator, Pontifica Universidad Catolica de Chile

Patients are needed to participate in a clinical research study for the treatment of Atrial Fibrillation

Santiago :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Santiago :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Temuco :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Temuco :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

China

Beijing :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Beijing : 1160.129.08018 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Beijing : 1160.129.08023 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Beijing : 1160.129.08024 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Beijing : 1160.129.08019 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Beijing : 1160.129.08017 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Beijing : Beijing Tiantan Hospital affilliated to Capital Medical University

A clinical trial to evaluate treatments using Pinocembrin for Injection for patients with Ischemic Stroke

Beijing : Prof Dayi Hu, National Coordinating Investigator, Peking University People Hospital

Patients are needed to participate in a clinical research study for the treatment of Atrial Fibrillation

Beijing :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Beijing :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Beijing :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Changchun : 1160.129.08039 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Changchun :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Changsha :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Changsha : 1160.129.08076 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Changsha : 1160.129.08007 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Chengdu : 1160.129.08041 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Dalian : 1160.129.08083 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Daqing :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Foshan : 1160.129.08102 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Guangzhou : Zhujiang Hospital, Southern Medical University

A clinical research study of Autologous BMSCs transplantation, Autologous EPCs transplantation and IV infusion of placebo for the treatment of Stroke or Infarction, Middle Cerebral Artery

Guangzhou :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Guangzhou : 1160.129.08001 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Guangzhou : 1160.129.08103 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Guangzhou : 1160.129.08005 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Guangzhou : 1160.129.08060 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Hangzhou :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Hangzhou : 1160.129.08011 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Hong Kong : Prince of Wales Hospital

A Phase 0 clinical study for patients with Atrial Fibrillation or Stroke

Jinan :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Jinan : 1160.129.08047 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Jinan : 1160.129.08050 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Nanchang : 1160.129.08065 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Nanjing :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Nanjing : 1160.129.08026 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Qingdao : 1160.129.08092 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Qingdao : 1160.129.08095 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Qingdao : 1160.129.08098 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Qingdao : 1160.129.08096 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Qingdao : 1160.129.08099 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

QingDao : 1160.129.08052 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Qingdao : 1160.129.08054 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Qingdao : 1160.129.08053 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Shanghai :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Shanghai : 1160.129.08035 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Shanghai : 1160.129.08106 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Shanghai : 1160.129.08032 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Shanghai : 1160.129.08037 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Shanghai : 1160.129.08014 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Shanghai : 1160.129.08027 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Shanghai : 1160.129.08012 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Shanghai : 1160.129.08036 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Shanghai : 1160.129.08029 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Shanghai :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Shenyang :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Shenyang : 1160.129.08081 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Shenyang : 1160.129.08080 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Shenyang : 1160.129.08091 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Shijiazhuang : 1160.129.08107 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Shijiazhuang : 1160.129.08066 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Suzhou :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Suzhou : 1160.129.08063 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Tianjin :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Tianjin : 1160.129.08043 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Wuhan :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Wuhan : 1160.129.08075 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Xiamen : 1160.129.08077 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Xiamen : 1160.129.08100 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Xi'An : 1160.129.08090 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Colombia

Armenia :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Barranquilla : Centro de Investigaciones y Proyectos en Neurociencias CIPNA LTDA IPS.

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Barranquilla : Centro Cientifico Asistencial Jose Luis Accini S.A.S

A Phase 3 clinical study for patients with Cardiovascular Disease

Barranquilla : Centro de Investigaciones y Proyectos en Neurociencias CIPNA LTDA IPS.

A Phase 3 clinical study for patients with Cardiovascular Disease

Barranquilla : Fundacion del Caribe para la Investigacion Biomedica - Fundacion BIOS

A Phase 3 clinical study for patients with Cardiovascular Disease

Barranquilla :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Barranquilla :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Bogota : 1160.129.24003 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Bogotá : 1160.129.24006 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Bogota D.C : Hospital Universitario San Ignacio

A Phase 3 clinical study for patients with Cardiovascular Disease

Bogota D.C. : Caja de Compensacion Familiar CAFAM - Sede Centro de Atencion en Salud CAFAM FLORESTA

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Bogota D.C. : Instituto de Investigacion Endocrinologia y Prevencion Metabolica - ENDOCARE LTDA.

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Bogota D.C. : Caja de Compensacion Familiar CAFAM, Sede Centro de Atencion en Salud CAFAM FLORESTA

A Phase 3 clinical study for patients with Cardiovascular Disease

Bogota D.C. : Dexa Diab Servicios Medicos Ltda

A Phase 3 clinical study for patients with Cardiovascular Disease

Bucaramanga :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Cali :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Cartagena : Centro de Diagnostico Cardiologico LTDA.

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Cartagena : Centro de Diagnostico Cardiologico LTDA.

A Phase 3 clinical study for patients with Cardiovascular Disease

Cartagena :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Cartagena de Indias : 1160.129.24007 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Espinal :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Floridablanca : Fundacion Cardiovascular de Colombia - Instituto del Corazon Floridablanca

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Manizales : 1160.129.24008 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Manizales :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Many Locations : Updated

A clinical trial seeking patients for a research study for the treatment of Atrial Fibrillation

Medellin Colombia : Hospital Pablo Tobon Uribe

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Pereira :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Quindio : 1160.129.24005 Boehringer Ingelheim Investigational Site

A clinical trial seeking patients for a research study for the treatment of Stroke or Atrial Fibrillation

Santafe de Bogotá :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Croatia

Krapinske Toplice : 1160.136.04002 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Opatija : 1160.136.04001 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Rijeka : 1160.189.26202 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Split : 1160.136.04011 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Zadar : 1160.136.04009 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Zagreb : Department of Neurology, University Hospital Sestre Milosrdnice

A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident

Zagreb : 1160.136.04007 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Zagreb : 1160.136.04003 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Zagreb : 1160.136.04005 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Zagreb : 1160.136.04006 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Zagreb : 1160.136.04010 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Zagreb : 1160.136.04004 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Czech Republic

Brno :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Brno : 1160.136.41009 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Brno : 1160.136.41001 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Brno :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Brno :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Cesky Krumlov :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Different : 4 Sites

A clinical research study of early standardised rhythm control for the treatment of Atrial Fibrillation or Stroke

Hodonin :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Hradec Kralove : Fakultni nemocnice Hradec Kralove

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Hradec Kralove :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Hradec Kralove :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Hranice :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Jablonec nad Nisou :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Karlovy Vary :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Kladno :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Kladno : 1160.136.41004 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Kolin :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Kolin N/A :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Litomysl :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Litovel : 1160.136.41006 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Mlada Boleslav :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Olomouc :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Ostrava :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Ostrava :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Plzen :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Prague : Dr Petr Jansky, National Coordinating Investigator, Cardiovaskular Center, Motol Univesity Hospital

Patients are needed to participate in a clinical research study for the treatment of Atrial Fibrillation

Praha :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Praha - Stodulky : Lékárna Hurka s.r.o.

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Praha - Stodulky : Lékárna Hurka, s.r.o.

A Phase 3 clinical study for patients with Cardiovascular Disease

Praha 10 : Fakultni nemocnice Kralovske Vinohrady

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Praha 10 :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Praha 10 N/A :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Praha 4 :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Praha 5 : Kardiologie a interni lekarstvi

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Praha 5 : Kardiologie a interni lekarstvi

A Phase 3 clinical study for patients with Cardiovascular Disease

Praha 5 : 1160.136.41010 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Praha 5 :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Praha 6 :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Roznov pod Radhostem : 1160.136.41011 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Slany :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Susice :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Teplice :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Trebic :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Uherske Hradiste :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Uherské Hradistì 6 :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Valasske Mezirici N/A :

A clinical research study of Rivaroxaban, Placebo and Standard of care for heart failure and coronary artery disease for the treatment of Heart Failure or Coronary Artery Disease

Zlin :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Denmark

Aalborg : 1160.136.18004 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Aarhus N : Aarhus Universitetshospital

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Copenhagen : EMS Copenhagen

Patients are needed to participate in a clinical research study for the treatment of Stroke

Different : 3 Sites

A clinical research study of early standardised rhythm control for the treatment of Atrial Fibrillation or Stroke

Esbjerg : Sydvestjysk Sygehus, Hjertemedicinsk Projektgruppe

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Esbjerg : Sydvestjysk Sygehus

A Phase 3 clinical study for patients with Cardiovascular Disease

Esbjerg : 1160.136.18007 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Frederiksberg : Prof Joern Dalsgaard Nielsen, National Coordinating Investigator, Bispebjerg & Frederiksberg Hospitals

Patients are needed to participate in a clinical research study for the treatment of Atrial Fibrillation

Hellerup : Gentofte Hospital

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Hellerup : Gentofte Hospital

A Phase 3 clinical study for patients with Cardiovascular Disease

Herlev : Herlev Universitetshospital

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Herning : Regionshospitalet Herning

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Hillerød : 1160.136.18005 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Hvidovre : Hvidovre Universitetshospital, Hjerte-lungemedicinsk afdeling

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Hvidovre : Hvidovre Universitetshospital, Hjerte-lungemedicinsk afdeling

A Phase 3 clinical study for patients with Cardiovascular Disease

Koege : Region Sjaelland Sygehus Nord, Koge Sygehus

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Kolding : 1160.136.18006 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Odense : 1160.136.18001 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Viborg : Regionshospitalet Viborg, Hjertemedicinsk Forskning, Hospitalsenhed Midt

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Viborg : Regions Hospital Viborg, HEM

A Phase 3 clinical study for patients with Cardiovascular Disease

Egypt

Many Locations : Updated

A clinical trial seeking patients for a research study for the treatment of Atrial Fibrillation

El Salvador

Valencia : 1160.136.03021 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Estonia

Tallin : 1160.136.38001 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Tallinn : 1160.136.38002 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Finland

Helsinki : Helsinki University Central Hospital

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Helsinki : Geri-Med Oy

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Helsinki : Sedes Oy - The Office of Jaakko Tuomilehto

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Helsinki : Helsinki University Central Hospital

A Phase 3 clinical study for patients with Cardiovascular Disease

Helsinki : Sedes Oy - The Office of Jaakko Tuomilehto

A Phase 3 clinical study for patients with Cardiovascular Disease

JyvaSkyla : Study Cor Oy

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Kerava : Laakarikeskus Aava Kerava/Aava Kerava Medical Center

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Kerava : Laakarikeskus Aava Kerava/Aava Kerava Medical Center

A Phase 3 clinical study for patients with Cardiovascular Disease

Kuopio : Ite Lasaretti

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Kuopio : Ite Lasaretti

A Phase 3 clinical study for patients with Cardiovascular Disease

Kuopio :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Kuusankoski :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Oulu : Terveystalo Oulu, Diapolis

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Oulu : Oulu University Hospital

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Oulu : Terveystalo Oulu, Diapolis

A Phase 3 clinical study for patients with Cardiovascular Disease

Oulu : Oulu University Hospital

A Phase 3 clinical study for patients with Cardiovascular Disease

Tampere : FinnMedi Oy

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Tampere : FinnMedi Oy

A Phase 3 clinical study for patients with Cardiovascular Disease

Tampere : Prof Pekka Raatikainen, National Coordinating Investigator, Univesrsity of Tampere

Patients are needed to participate in a clinical research study for the treatment of Atrial Fibrillation

Tampere :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Valkeakoski : Valkeakoski Hospital

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Vantaa : Vantaa Research Center

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Vantaa : Vantaa Research Center

A Phase 3 clinical study for patients with Cardiovascular Disease

Vantaa :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

France

Agen : 1160.136.13121 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Aix en Provence : 1160.136.13111 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Aix en Provence : 1160.136.13102 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Bagnols sur Ceze : 1160.136.13035 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Bar le Duc : 1160.136.13155 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Bayonne Cedex : 1160.136.13143 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Besancon : 1160.136.13039 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Beziers : 1160.136.13036 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Beziers : 1160.136.13040 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Béziers : 1160.136.13037 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Bordeaux : 1160.136.13004 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Bordeaux : 1160.136.13138 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Bour-en-Bresse : 1160.136.13148 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Brest : 1160.136.13140 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Broglie : 1160.136.13045 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Bruay la Buissière : 1160.136.13054 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Caen : 1160.136.13031 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Caen : 1160.136.13147 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Cannes : 1160.136.13014 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Chalon-Sur-Saône : 1160.136.13103 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Clermont Ferrand : 1160.136.13055 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Corbeil Essonnes : 1160.136.13101 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Corbeil-Essonnes : Centre Hospitalier Sud-Francilien

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Corbeil-Essonnes : Centre Hospitalier Sud-Francilien -

A Phase 3 clinical study for patients with Cardiovascular Disease

Corbeil-Essonnes : 1160.136.13057 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Different : 2 Sites

A clinical research study of early standardised rhythm control for the treatment of Atrial Fibrillation or Stroke

Dijon : 1160.136.13073 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Dole : 1160.136.13074 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Evreux : 1160.136.13012 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Firminy : 1160.136.13051 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

La Tronche : 1160.136.13006 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Le Bourget : 1160.136.13125 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Le Chesnay : 1160.136.13084 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Le Coudray : 1160.136.13058 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Le Mans : 1160.136.13032 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Libourne : 1160.136.13008 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Lille : 1160.136.13141 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Limoges : 1160.136.13078 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Limoges Cedex :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Lyon : Hopital Neurologique de Lyon, Service d'urgences Neurovasculaires

A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident

Lyon cedex 7 : 1160.136.13135 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Maisons Alfort : 1160.136.13052 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Marseille : 1160.136.13093 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Marseille : 1160.136.13024 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Marseille : 1160.136.13075 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Marseille : 1160.136.13154 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Marseille : 1160.136.13142 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Metz-Tessy : 1160.136.13081 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Montauban : 1160.136.13053 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Montbeliard : 1160.136.13033 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Montfermeil : 1160.136.13001 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Montfermeil : 1160.136.13048 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Montpellier : 1160.136.13072 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Montreuil : 1160.136.13094 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Nancy : 1160.136.13144 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Nantes : Nouvelles Cliniques Nantaises

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Nantes : Nouvelles Cliniques Nantaises

A clinical trial to evaluate treatments for patients with Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke (WATCHMAN)

Neuilly sur Seine : 1160.136.13064 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Nîmes : 1160.136.13085 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Orléans : 1160.136.13065 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Paris : BICHAT HOSPITAL Department of neurology and stroke center

A clinical trial seeking patients for a research study for the treatment of Ischemic Stroke, Transient Ischemic Attack or Atherosclerotic Stenosis

Paris : BICHAT HOSPITAL Departement of Neurology

A clinical trial seeking patients for a research study for the treatment of Ischemic Stroke, Transient Ischemic Attack or Atherosclerotic Stenosis

Paris : Groupe hospitalier Bichat Claude Bernard

A clinical trial to evaluate treatments for patients with Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke (WATCHMAN)

Paris : Prof. Jean-Yues LeHeuzey, National Coordinating Investigator, Hopital Europeen Georges Pompidou

Patients are needed to participate in a clinical research study for the treatment of Atrial Fibrillation

Paris : 1160.136.13105 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Paris : 1160.136.13146 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Paris : 1160.136.13120 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Paris : 1160.136.13123 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Paris : 1160.136.13145 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Paris : 1160.136.13071 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Paris :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Paris :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Paris Cedex 15 :

Patients are needed to participate in a clinical research study to evaluate Prevention & Control

Pau : Centre Hospitalier de PAU - Service de cardiologie

A Phase 3 clinical study for patients with Cardiovascular Disease

Rosiers d'Egletons : 1160.136.13042 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Roubaix : 1160.136.13153 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Rouen : 1160.136.13130 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Saint André lez Lille : 1160.136.13152 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Saint Benoit : 1160.136.13114 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Saint Etienne : 1160.136.13108 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Saint-Yrieix-la-Perche : 1160.136.13026 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

St Raphael : 1160.136.13091 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Strasbourg : 1160.136.13067 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Tarbes : 1160.136.13110 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Toulouse : 1160.136.13023 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Tourcoing : Hopital Guy Chatiliez

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Tourcoing : Hopital Guy Chatiliez

A Phase 3 clinical study for patients with Cardiovascular Disease

Tourcoing : 1160.136.13003 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Tours : 1160.136.13113 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation

Tours : 1160.136.13116 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study for the treatment of Stroke or Atrial Fibrillation